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1. Phylogenetic background 
 
1.1. Herpesvirales 
 
In 2009, the International Committee on Taxonomy of Viruses (ICTV) assigned a new 
order, Herpesvirales (Davison et al., 2009). The order Herpesvirales is comprised of large DNA 
viruses that infect a wide variety of animals, from mammals to bony fish and molluscs. This order 
contains three distinct families: the Herpesviridae that includes herpesviruses of mammals, birds, 
and reptiles; the Alloherpesviridae that includes the herpesviruses of fish and frogs, and 
the Malacoherpesviridae that contains a virus of oysters (bivalve) (Wolf and Darlington, 1971; 
Davison et al., 2005; Davison et al., 2009). 
The Herpesviridae family is further subdivided into three distinct subfamilies, alpha (α)- , beta 
(β)- and gamma (γ)- herpesviruses based on their host range, clinical symptoms, disease severity, 
tissue tropism and replication kinetics (Roizman and Baines, 1991; Roizman et al., 2001). 
Alphaherpesvirinae and Betaherpesvirinae can be considered as ‘lytic’ because they cause a lytic 
replication in a broad array of cells. However, in specific cell types they may stay lifelong in a 
latent stage (i.e. neurons). Gammaherpesvirinae replicate in a narrow range of cells and often 
remain latent and persistent in cells (Ackermann, 2006). The subfamilies are subdivided into 
genera, based on similarities in genome sequence arrangement, DNA sequence homology and 
relatedness of important viral proteins. The phylogenetic tree of the Herpesvirales is shown in 
Figure 1. 
 
1.2. Alphaherpesvirinae 
 
In general, Alphaherpesviruses are recognized to have a broad host cell range with a rapid 
replication cycle, followed by destruction of the host cell in a wide variety of susceptible cells and 
swift spread among these cells. They use multiple strategies to hijack infected host immune cells, 
establish latent infection and evade antiviral immune responses in order to eventually permit the 
production and subsequent dissemination of infectious virions (Fields et al., 2007; Steukers et al., 
2012). Based on sequence analysis and molecular criteria, the Alphaherpesvirinae are subdivided 
into four genera: Simplexvirus, Varicellovirus, Mardivirus and Iltovirus. The members of the 
Simplexvirus genus are human herpesvirus 1 (herpes simplex type 1; HSV-1), human herpesvirus 
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2 (herpes simplex type 2; HSV-2), herpesvirus B (HVB), bovine herpesvirus 2 (BoHV-2), 
herpesvirus saimiri 1 (HVS-1) and simian agent 8 (SA8). Equine herpesvirus 1 (EHV-1) has been 
classified to the Varicellovirus genus together with pseudorabies virus (PRV), varicella zoster 
virus (VZV), bovine herpesvirus 1 (BoHV-1), feline herpesvirus 1 (FHV-1), equine herpesvirus 3 
(EHV-3) and equine herpesvirus 4 (EHV-4). Marek’s disease virus 1 (MDV-1), Marek’s disease 
virus 2 (MDV-2) and herpesvirus of turkeys (HVT) belong to the Mardivirus genus and infectious 
laryngotracheitis virus (ILTV) belongs to the Iltovirus genus (Roizman and Baines, 1991; Tischer 
and Osterrieder, 2010; Zaichick et al., 2011). 
 
 
Figure 1. Herpesvirales phylogenetic tree (adapted from Davison, 2002). 
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2. Equine herpesvirus type 1  
 
2.1. Virus structure 
 
There are four morphologically distinct components which make up the equine herpesvirus type 1 
(EHV-1) virion: the viral genome, the capsid, the tegument and the envelope. The linear double 
stranded DNA genome of approximately 150 kbp is enclosed in an icosadeltahedral capsid 
(approximately 125 nm diameter), which is surrounded by a tegument, proteinaceous matrix. The 
tegument is encoded by at least 15 genes and contains many virus-coded proteins. The tegument 
protein is encompassed by a lipid envelope, containing membrane-associated proteins (Fields et 
al., 2007; Roizman and Knipe, 2001; Roizman and Pellett, 2001; Davison et al., 2009). 
The general structure of an EHV-1 virion is given in Figure 2. 
 
 
 
Figure 2. Structure of an EHV-1 virion (adapted from Paillot et al., 2008). 
 
 Alphaherpesvirinae glycoproteins are named according to the nomenclature established for the 
prototype member of the subfamily, herpes simplex virus type 1 (HSV-1). Homologues of 
glycoproteins gB, gC, gD, gE, gG, gH, gI, gK, gL, gM, gN have been identified in the EHV-1 
genome. Viral glycoprotein gp2 is unique to EHV-1. Envelope glycoproteins have three parts: the 
external ectodomain, a transmembrane segment, and the internal part, the endodomain. The exact 
locations of the EHV-1 glycoprotein genes in the genome have been determined by sequence 
analysis. These 12 envelope glycoproteins are involved in virus attachment, penetration, egress, 
cell-to-cell spread, pathogenicity and virulence (Turtinen and Allen, 1982; Osterrieder and Van de 
Walle, 2010).  
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Glycoprotein B (gB) 
Envelope glycoprotein B is highly conserved throughout the Herpesviridae family and presumably 
has a function in attachment and membrane fusion (Eisenberg et al., 2012; Li et al., 2006). EHV-
1 gB plays a pivotal role in penetration and in direct cell-to-cell spread of virions (Neubauer et al., 
1997, Wellington et al., 1996b). Perturbations of the carboxyl terminal domains of gB facilitate 
gB-mediated cell-to-cell fusion, however the absolute requirement of this glycoprotein in the 
fusion process in EHV-1 is still somewhat ambiguous (Neubauer et al., 1997). Glycoprotein B 
along with major nucleocapsid proteins are some of the most antigenic EHV-1 proteins (Ahmed 
et al., 1993).  
 
Glycoprotein C (gC) 
EHV-1 gC binds to heparan sulfate (HS) molecules, a heparin-like moiety on the cell surface, and 
initiates cell entrance of the virus (Sugahara et al., 1997; Osterrieder, 1999; Azab et al., 2010). 
Hydrophilic regions of the gC may be responsible for binding to heparin (Sugahara et al., 1997). 
Glycoprotein C is capable to bind the third component of complement (C3), which allows the virus 
to escape from complement-mediated inactivation of cell-free viruses and complement-mediated 
lysis of infected cells (Azab et al., 2010; Huemer et al., 1995). EHV-1 gC also plays a major role 
in the release of virions (Osterrieder, 1999).  
 
Glycoprotein D (gD) 
The EHV-1 envelope glycoprotein D is encoded by a unique short (Us) segment of the EHV-1 
genome with only 26% and 20% of its residues matching PRV gD and HSV-1 gD, respectively, 
and consists of 385aa  (Audonnet et al., 1990; Elton et al., 1992; Flowers and O'Callaghan, 1992; 
Love et al., 1992; Whalley et al., 1991). gD is conserved among almost all alphaherpesviruses 
(Connolly et al., 2011). EHV-1 gD is required for virus entry, which occurs via cell-cell fusion 
and/or endocytosis (Csellner et al., 2000; Van de Walle et al., 2008; Azab and Osterrieder, 2012). 
As shown in Table 1, the cell type and the respective receptors are the main determinants of 
whether the fusion process occurs at the plasma membrane or through an endocytic route of entry. 
Previous studies have proven that the C-terminal region of HSV-1 gD (encompassing residues 260 
to 310) is required to trigger fusion (Lazear et al., 2008; Connolly et al., 2011). This mechanism 
of gD triggering fusion is shared among alphaherpesviruses (Geraghty et al., 1998). Glycoprotein  
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Table 1. Entry of EHV-1 into different cell types. 
Cell type Entry pathway(s) Receptor(s) References 
equine PBMC endocytosis αV integrins Van de Walle et al., 2008; 
Azab and Osterrieder, 2012 
 
equine 
endothelial cells 
fusion at the plasma membrane 
(endocytosis at low efficiency) 
MHC-I Van de Walle et al., 2008; 
Azab et al., 2014; Kurtz et 
al., 2010 
 
equine dermal 
cells 
fusion at the plasma membrane MHC-I Frampton et al., 2007; 
Sasaki et al., 2011 
 
RK13 cells fusion at the plasma membrane MHC-I Frampton et al., 2007 
 
CHO-K1 cells endocytosis αV integrins, 
glycosaminoglycans 
Frampton et al., 2005: Van 
de Walle et al., 2008 
 
D is the key receptor-binding protein of numerous alphaherpesviruses (Campadelli-Fiume et al., 
2007). In general, the gD receptors include members of the tumor necrosis factor (TNF) receptor 
family (HveA), the poliovirus receptor family (HveB and HveC, members of the immunoglobulin 
superfamily), integrins, and a modified form of heparan sulfate called 3-O-sulfated heparan sulfate. 
The cells that express integrin alpha V, HveA, HveB, HveC, and heparan sulfate can be infected 
by EHV-1 (Frampton et al., 2005; Azab and Osterrieder, 2012). For EHV-1, Kurtz et al. (2010) 
showed that the major histocompatibility complex class I (MHC-I) molecules play a role as a gD 
receptor for EHV-1 entry into equine cells. Recently, Azab et al. proved that EHV-1 and EHV-4 
target classical polymorphic MHC-I molecules as viral entry receptors (Azab et al., 2014). The 
entry of some alphaherpesviruses through an endocytic route was described for certain cell types, 
such as HeLa and Chinese hamster ovary (CHO-K1) cells, which depend on binding of gD to its 
receptor, integrin alpha V (Nicola and Straus, 2004; Nicola et al., 2005). Entry of EHV-1 has also 
been suggested to occur via an endocytic pathway to infect important cell populations. The 
interaction between cellular integrins and an arginine, serine, and aspartic acid (RSD) motif of 
EHV-1 envelope gD plays a critical role for virus entry via endocytosis (Van de Walle et al., 2008). 
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Monoclonal antibodies against gD can neutralize EHV-1 infectivity and hamper virus peneteration 
into the cells (Csellner et al., 2000; Van de Walle et al., 2008).  
 
Glycoprotein E (gE) 
In general, glycoprotein E together with glycoprotein I (complex gE/gI) forms a non-covalently 
bound heterodimer that functions in viral cell-to-cell spread and transsynaptic spread of infection 
throughout the host nervous system (Favoreel et al., 1999). gE is a non-essential glycoprotein, 
except for Marek's disease virus serotype 1 and varicella-zoster virus (Mo et al., 2002; Schumacher 
et al., 2001). Although the gE/gI complex is involved in cell-to-cell spread of EHV-1, the complex 
is not involved in the process of virus maturation and release or in virus attachment and penetration 
(Matsumura et al., 1998). gE is known as a virulence factor of EHV-1 in horses and intramuscular 
vaccination with an attenuated gE deletion mutant provided foals with partial protection against 
EHV-1 respiratory disease (Tsujimurai et al., 2009).  
 
Glycoprotein G (gG) 
Glycoprotein G is a non-essential protein of EHV-1 that can be found in three distinct isoforms: a 
full-length membrane-bound form, a smaller membrane-bound form lacking the majority of the 
extracellular domain, and an important secreted form that is made up of the extracellular domain 
released by cleavage from the membrane anchor (von Einem et al., 2007; Osterrieder and Van de 
Walle, 2010). Both the secreted form and membrane-bound form of EHV-1 gG bind chemokines 
(Osterrieder and Van de Walle, 2010; Van de Walle et al., 2008). Therefore, gG acts as a viral 
chemokine binding protein (vCKBP), by blocking interaction of chemokines with both chemokine 
specific receptors and glycosaminoglycans (Thormann et al., 2012). It has been shown that the 
hypervariable region of EHV-1 gG is responsible for chemokine binding and function (Van de 
Walle et al., 2009). One of the notable functions of gG is interfering with leukocyte migration in 
tissue which can contribute to virulence and organ dissemination of EHV-1 (Osterrieder and Van 
de Walle, 2010). By performing chemotaxis assays, it was shown that gG of EHV-1 is able to 
hinder transmigration of leukocytes in response to recombinant equine interleukin 8 (IL8, also 
designated CXCL8) (Van de Walle et al., 2007; Thormann et al., 2012).   
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Glycoprotein H (gH) 
Glycoprotein H forms a heterodimer with glycoprotein L (complex gH/gL) and this complex acts 
as a fusion regulator for many herpesviruses (Eisenberg et al., 2012; Azab et al., 2012). Analysis 
of the gH structure revealed that it has three distinct domains in the N-terminal region (domain 
H1) that bind to gL (Chowdary et al., 2010). In the absence of gL, expression of gH polypeptide 
in transfected cells is not folded and processed correctly. Recently, it has been shown that EHV-1 
gH and cellular α4β1 integrins are important determinants in the choice of virus cellular entry 
pathways (Azab et al., 2013). 
 
Glycoprotein I (gI) 
Glycoprotein I forms a non-covalently bound heterodimer with gE (complex gI/gE) which 
facilitates cell-to-cell spread of viruses and is one of the important factors of EHV-1 virulence 
(Matsumura et al., 1998). Yet, some aspects of the EHV-1 gI structure and function are still unclear 
and need to be elucidated.  
 
Glycoprotein K (gK) 
The gK of herpesviruses is present in the virions and also on the plasma membrane of cells that 
are infected with the virus. The EHV-1 gK is required for efficient cell-to-cell spread and virus 
egress (Neubauer and Osterrieder, 2004). Immediate early (IE) phosphoprotein of EHV-1 binds to 
the transcription initiation site of the gK promoter sequences, thereby repressing transcription of 
this true late gene (Kim et al., 1999; Derbigny et al., 2000). 
 
Glycoprotein L (gL) 
Glycoprotein L is associated with gH, however the specific role of the gH/gL complex is the least 
well understood in the herpesvirus family. gL is an essential glycoprotein in some herpesviruses, 
but its function and role in the EHV-1 replication cycle remains largely unknown (Stokes et al., 
1996; Roop et al., 1993). A properly formed gH/gL heterodimer is needed for attachment, virus 
entry, and virus-induced cell-to-cell fusion of alphaherpesviruses (Eisenberg et al., 2012). In spite 
of the fact that alphaherpesviruses lacking gH/gL are unable to enter cells, they are able to attach 
to the cell surface. Therefore, the role of the gH/gL in virus entry is important during the virus 
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envelope plasma membrane fusion event and is not required for virion or receptor binding 
(Eisenberg et al., 2012). 
 
Glycoprotein M (gM) 
The conserved but nonessential gM glycoprotein represents a hydrophobic class III membrane 
protein that contains eight putative transmembrane domains and form a complex with gN 
(pUL49.5) (Osterrieder et al., 1996; Jöns et al., 1998; Crump et al., 2004). Processing of gM inside 
the EHV-1-infected cell depends on the expression of gN (Rudolph et al., 2002). EHV-1 gM is 
associated with not only the entry of the virus but also the direct spread from cell to cell 
(Osterrieder et al., 1996). Deletion of gM in strain RacL11 of EHV-1 leads to a 50% reduction in 
plaque size compared to the wild type, and a 50 to 100 times less production of extracellular virus 
(Osterrieder et al., 1996; Osterrieder et al., 1997). 
 
Glycoprotein N (gN) 
The function of gN is not well characterized in EHV-1. Rudolph et al have shown that gN is 
necessary and sufficient for functional processing of glycoprotein M, and that it is required for 
efficient virus replication (Rudolph et al., 2002). Alphaherpesviruses evade elimination by 
cytotoxic T lymphocytes through specific interfering with the transporter associated with antigen 
processing (TAP) and subsequent antigen-presenting function of major histocompatibility 
complex class I (MHC I) and in this context, gN has been shown to act as a TAP inhibiting 
molecule (Verweij et al., 2011). 
 
Glycoprotein 2 (gp2) 
The unique mucin-like high molecular mass (Mr) glycoprotein 2 (gp2) has only been recognized 
in the equid alphaherpesviruses. The gp2 (also known as gp300) is a large (250-kDa) glycoprotein 
of EHV-1 and is encoded by gene 71, located within the unique short region of the genome, with 
abundant O-glycosylation sites in the N-terminal part of the molecule (Smith et al., 2005; 
Wellington et al., 1996a; Hansen et al., 1995). gp2 is a major EHV-1 virulence factor. Mutation of 
gene 71 attenuated the virus but did not inhibit virus replication in the murine lung (Smith et al., 
2005; Frampton et al., 2002). Deletion of gp2 impairs virus cell-to-cell spread and secondary 
envelopment (Rudolph et al., 2002; Sun et al., 1996). Smith and colleagues suggest that gp2 act as 
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a signaling molecule and this function is being explored by generating mutant viruses (strain 
KyARgp2F) that lack the ability to release the secreted form of the protein (Smith et al., 
2005).Taken together, this envelope glycoprotein plays an important role in EHV-1 pathogenesis. 
 
 
2.2. Virus genome and replication cycle 
 
Genomic organization 
The complete genome sequence of EHV-1, with 80 open reading frames (ORFs), has been 
elucidated in 1992 by Telford et al. (Telford et al., 1992). The genome of the virus is organized as 
a linear double-stranded type D DNA of approximately 150kbp with a base composition of 56 to 
57 % G + C (Telford et al., 1992). Since four ORFs are duplicated, the genome is considered to 
contain at least 76 distinct genes with a potential to code for 77 different proteins due to alternative 
splicing of ORF64 (Telford et al., 1992; Harty et al., 1989). The EHV-1 genome is divided into 2 
covalently linked components: the S or short component that consists of a unique (US) sequence 
and the L or long region that comprises a unique (UL) sequence, with the latter bracketed by two 
inverted repeat regions, namely the internal repeat (IR) and terminal repeat (TR), Figure 3, (Telford 
et al., 1992; Yalamanchili and O'Callaghan, 1990). 
 
 
  
  
 
 
Figure 3. Genomic organization of EHV-1. TR, terminal repeat; IR, internal repeat; U, unique. 
 
 
Replication cycle 
A schematic representation of the various steps of the EHV-1 replication cycle is shown in Figure 
4. 
IRS IRS IRL TRL 
US UL 3' 5' 
S-component L-component 
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Figure 4. The EHV-1 replication cycle (Vandekerckhove, 2011). The first step in the replication 
cycle is the attachment of free virions to the surface of the target cell (1). The binding is initially 
unstable and includes interaction of viral envelope glycoproteins gB and gC with heparan sulfate 
glycosaminoglycan moieties of the cell surface (2a). Subsequently, EHV-1 can enter cells via 2 
pathways, depending on the infected cell type. In equine endothelial, equine dermal and rabbit 
kidney cells, fusion of the viral envelope with the plasma membrane occurs through interaction of 
gD with an entry receptor, possibly MHC-1 (2b). In equine PBMCs and CHO-K1 cells, entry 
occurs via a nonclassical endocytic pathway mediated by the interaction between cellular αV 
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integrins and an RSD motif at amino acid (aa) positions 152-154 present in EHV-1 gD (3). The 
nucleocapsid is released into the cytoplasm (4) and transported to the nucleus along microtubules 
(5). In the nucleus, DNA replication (6) and transcription (7) occur. The genome is transcribed in 
a cascade-like manner with first the immediate-early (IE) genes, then the early (E) genes and 
finally the late (L) genes. RNA molecules are transported to the cytoplasm and translated to 
proteins (8). Capsid proteins are redirected into the nucleus where assembly of the capsid occurs 
(9). Subsequently, DNA is pulled into the newly formed capsids and hence nucleocapsids are 
assembled (10). The nucleocapsids leave the nucleus via budding through the inner leaflet of the 
nuclear membrane (11), hereby requiring their primary envelope (12). Subsequent fusion with the 
outer leaflet of the nuclear membrane results in the entry of naked nucleocapsids into the 
cytoplasm (13). The nucleocapsids acquire their secondary envelope at the Golgi apparatus (14) 
and then leave the cell via vesicle-mediated exocytosis (15, 16, 17). 
 
The replication cycle of EHV-1, and alphaherpesviruses in general, begins with the attachment of 
free virions to the surface of a target cell, a process in which at least five viral glycoproteins are 
involved: gB, gC, gD and the gH-gL complex (Spear and Longnecker, 2003). Therefore, the cycle 
starts when viral gC undergoes transient interactions with cellular surface receptors (Kurtz et al., 
2010; Sasaki et al., 2011). Glycoprotein D establishes a more stable attachment, binding to one of 
its receptors (Geraghty et al., 1998; Granzow et al., 2005). While entry receptors for several 
alphaherpesviruses, such as herpes simplex virus 1 (HSV-1), herpes simplex virus 2 (HSV-2), 
pseudorabies virus (PRV) and bovine herpesvirus 1 (BoHV-1), have already been identified, 
studies on entry receptors for EHV-1 are ongoing. Some of these receptors are listed in Table 1. 
Following this interaction, the viral envelope is fused with the target cell membrane with the 
concerted action of the viral fusion protein gB and complex gH-gL, releasing the particle into the 
cytoplasm of the target cell (Spear and Longnecker, 2003).  Entry of EHV-1 into the cells happens 
by direct fusion at the plasma membrane or after endocytic uptake (Azab et al., 2013; Frampton et 
al., 2007; Hasebe et al., 2009; Van de Walle et al., 2008). After nucleocapsid release in the 
cytoplasm, capsids misuse the cellular motor protein dynein for direct microtubule-based transport 
towards the nuclear pore complexes. At the nuclear pores, docking complexes are formed and the 
viral DNA is released within the nucleus (Sodeik et al., 1997; Zaichick et al., 2011).  In the infected 
nucleus, a cascade of transcription drives several phases of the viral replication cycle.  Viral genes 
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can be subdivided into three categories and are sequentially transcribed: immediate-early (IE), 
early (E) and late (L) genes (Nicoll et al., 2012). First, the immediate-early (IE) gene is transcribed 
which results in the production of a regulatory protein which is pivotal for activating transcription 
of early and late genes. Early genes encode the proteins involved in virus replication and late genes 
encode the viral structural proteins. The IE transcription is orchestrated by a transactivator protein, 
brought into the cell as a tegument protein, namely VP16 (LaBoissiere and O'Hare, 2000). This 
tegument protein, VP16, transactivates the transcription of the only immediate-early protein of 
EHV-1, which is encoded by ORF64 (the homologue to ICP4 of HSV-1) and transcribed by 
cellular RNA polymerase II (Paillot et al., 2008). The early (E) gene products (UL5, UL8, UL9, 
UL29, UL30, UL42 and UL52 gene products) mainly play a role in nucleotide metabolism and 
DNA synthesis (Lehman and Boehmer, 1999). The transcriptional cascade continues with 
structural proteins, enzymes involved in assembly, and membrane proteins. UL31 and UL34 viral 
proteins are required in the assembly of all herpesviruses (Mettenleiter et al., 2006).  With the 
involvement of these proteins and US3 protein kinases, nucleocapsids bud through the inner 
nuclear membrane thereby achieving tegument proteins and a primary envelope. Primary 
enveloped nucleocapsids, located in the perinuclear space, will undergo a subsequent fusion with 
the outer nuclear membrane. Capsids subsequently obtain their secondary, mature envelope at 
vesicles derived from the trans-Golgi network. Then, the mature virions are transported to the cell 
surface within sorting vesicles and released by fusion of glycoprotein-containing Golgi derived 
vesicles with the plasma membrane (Mettenleiter et al., 2009; Mettenleiter et al., 2006; Pomeranz 
et al., 2005).  
 
2.3. Pathogenesis of EHV-1 
 
EHV-1 is highly contagious. Transmission of the virus occurs by direct contact with infected saliva 
or nasal discharge. Although to a lesser extent, EHV-1 can be transmitted by aerosol or fomites 
(feed, clothing, boots, hands, etc.) (Allen and Bryans, 1986). Among the nine equine herpesviruses 
identified up till now, EHV-1 is one of the most pathogenic herpesviruses of horses. An overview 
of the complete pathogenesis of EHV-1 is given in Figure 5. 
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Figure 5. Schematic overview of the pathogenesis of EHV-1. After inhalation or oral uptake, the 
virus replicates in the epithelium of the upper respiratory tract (URT). Then, by infecting 
monocytic cells and T lymphocytes it reaches lymph nodes and blood vessels. Replication of EHV-
1 in the endothelial cells of the vessels of the pregnant uterus or the CNS induces abortion or 
neurological disease. EHV-1 can establish latency after primary infection, from which it can be 
reactivated and may cause diseases 
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Infection of the respiratory epithelium 
 
After inhalation or oral uptake of EHV-1 by the horse, the virus replicates in the epithelial cells of 
mainly the upper respiratory tract resulting in viral shedding and distinct herpetic lesions (Kydd et 
al., 1994; Patel and Heldens, 2005). The infected upper respiratory tract includes nasal septum, 
turbinates, nasopharynx, soft palate and trachea (Van Maanen, 2002; Gryspeerdt et al., 2010; 
Vandekerckhove et al., 2010; Allen et al., 1994). In the stage of EHV-1 replication in the upper 
respiratory tract, large amounts of virus are shed from the respiratory mucosa of infected animals 
into the external environment. Viral shedding generally starts at 1 day post infection and can last 
for 7 to 14 days post infection (Gryspeerdt et al., 2010; Heldens et al., 2001). Infection of the lower 
respiratory tract including epithelial cells, endothelial cells and leukocytes of lungs can be 
observed from day 2 to day 13 post viral infection, with a peak on day 9 when occasional non-
occlusive thrombi may occur in the pulmonary interstitium (Kydd et al., 1994). The majority of 
respiratory infections cause a subclinical course. However, animals which are severely affected 
show vasculitis, haemorrhages and edema in the lungs and may die suddenly during a period of 
respiratory distress. The airway form of EHV1 infection is referred to as rhinopneumonitis and is 
characterized by rhinopharyngitis and tracheobronchitis (del Piero and Wilkins, 2001; del Piero et 
al., 2000).  
Replication of EHV-1 in the mucosal epithelium of the URT happens in a plaque-wise manner. 
Plaques do not breach the basement membrane barrier. Instead, individual infected leukocytes 
(mainly monocytic cells and T lymphocytes) are hijacked by the virus to cross the basement 
membrane barrier en route to the blood vessels of the lamina propria and the draining lymph nodes 
(Van Maanen, 2002; Gryspeerdt et al., 2010; Vandekerckhove et al., 2010).  
 
Cell-associated viremia 
After a first replication in the respiratory epithelial cells, EHV-1 disseminates through the 
basement membrane (BM) barrier by single infected mononuclear immune cells, en route to blood 
vessels and draining lymph nodes. This results in a cell-associated viremia lasting for up to 8 to 
18 days post infection (Kydd et al., 1996; Gryspeerdt et al., 2010; Edington et al., 1986; Gibson et 
al., 1992). The infected cells are identified as predominantly monocytic cells and T-lymphocytes 
(Table 2) (Gryspeerdt et al., 2010; Vandekerckhove et al., 2010). During viremia, the majority of 
Introduction 
 
22 
 
infected mononuclear immune cells do not show viral envelope proteins on their surface (van der 
Meulen et al., 2006). It has been well documented that peripheral blood mononuclear cells 
(PBMCs) are susceptible to EHV-1 infection in both in vitro and in vivo studies (Kydd et al., 1994; 
van Der Meulen et al., 2000; Gryspeerdt et al., 2010; Vandekerckhove et al., 2010; Wilsterman et 
al., 2011; Goodman et al., 2007; Van de Walle et al., 2009). However, which PBMC 
subpopulations are infected with EHV-1, and the load of virus in each cell subpopulation is a 
matter of debate. It can be said that the majority of EHV-1-infected cells are of the monocytic 
lineage, whereas T-lymphocytes can be considered as the second most important infected cells. 
Therefore, these different immune cell populations will be discussed here in detail. 
 
Table 2. Identification of EHV-1-infected leukocytes in nasal mucosa and PBMC upon in vivo, ex 
vivo and in vitro inoculation. 
Tissue/Cells Condition % of EHV-1-infected 
cells in a population of 
mononuclear cells 
% of mononuclear cells in a 
population of EHV-1-infected 
cells 
 
References 
nasal 
mucosa 
in vivo  monocytic cells: 53.4 ± 22.8 % 
T-cells: 16.2 ± 11.7 % 
B-cells: 0.3 ± 0.8 % 
 
Gryspeerdt  
et al., 2010 
 ex vivo monocytic cells:  
11.5 ± 4.5 % 
 
 
monocytic cells: 74.1 ± 7.3 % 
T-cells: CD4+: 14.3 ± 7.4 % 
              CD5+: 12.5 ± 4.4 % 
              CD8+: 4.9 ± 1.6 % 
B-cells: 0.0 ± 0.0 % 
Vandekerckhove 
et al., 2010; 
Bannazadeh 
Baghi and 
Nauwynck, 2014 
 
PBMC in vitro 
 
 
 
monocytic cells:  
7.5 ± 4.4 % 
T&B-lymphocytes:  
0.9 ± 0.6 % 
 
 
monocytes: > 60% 
T-cells: CD4+: 1.4 ± 1.6 % 
              CD8+: 3.7 ± 4.7 % 
B-cells: > 20 % 
Van der Meulen 
et al., 2000; Yeo 
et al., 2013; 
Ma et al., 2010  
 in vivo mononuclear cells:                    
0.0004 % 
monocytic cells: 78.5 % 
T-cells: CD5+: 21.5 % 
 
Gryspeerdt  
et al., 2010 
 
Introduction 
 
23 
 
Monocytes/macrophages - Monocytes and macrophages engulf pathogens and apoptotic cells and 
produce immune effector molecules. Upon infection, monocytes are rapidly recruited to the 
infected site of the tissue, where they differentiate into tissue macrophages (Jakubzick et al., 2013; 
Yang et al., 2014). Monocytic cells have been shown to have a central role in the pathogenesis of 
several viruses such as human herpes virus 1 (HSV-1), Epstein-Barr virus (EBV) and human 
cytomegalovirus (HCMV) (Linnavuori and Hovl, 1981; Savard et al., 2000; Bentz et al., 2006). 
Viral infection of monocytes and macrophages at different stages of differentiation has different 
outcomes and may result in the alteration of important cellular functions. Several studies showed 
that all equine PBMC subpopulations are susceptible to EHV-1 in vitro, but that cells of the 
monocytic lineage (CD172a+cells), are the main infected subpopulation (Gryspeerdt et al., 2010; 
Vandekerckhove et al., 2010; van der Meulen et al., 2000; van der Meulen et al., 2006). 
 
Dendritic cells - Dendritic cells (DCs) represent a heterogeneous population of immune cells 
which are specialized antigen-presenting cells (APCs) and most capable of efficiently activating 
naïve T cells to initiate immune responses (Rossi and Young, 2005; Mellman and Steinman, 2001). 
DCs are a target for many invading viruses, notably from the Herpesviridae family, such as HSV-
1, HSV-2, VZV, EBV, HCMV, mouse cytomegalovirus (MCMV) and human herpesvirus 6 
(HHV-6) (Rinaldo and Piazza, 2004). These viruses have developed several mechanisms to escape 
immune surveillance by DCs and to misuse these cells to disseminate through the body. In 1998, 
Steinbach and colleagues showed for the first time the infection of murine DCs with EHV-1 
(Steinbach et al., 1998). Their data indicated that murine DCs may mediate a restricted infection. 
One year later, in 1999, Siedek et al. proved that EHV-1 is able to infect equine DCs in vitro 
(Siedek et al., 1999). Regarding the migratory life-style of DCs, the susceptibility to infection with 
EHV-1 possibly plays an important role in transporting infectious virus, from the mucosal surface 
of the respiratory tract to internal organs of the body including lymph nodes and endothelium of 
target tissues.  
 
Lymphocytes - Lymphocytes play an essential role in combatting microbial infections. The 
interaction between viruses and lymphocytes is known to play a central role in on the one hand 
spread, and on the other hand control of viral infection within the host (Rudraraju et al., 2013; 
Shacklett et al., 2003). Previous studies proved that the main targets of infection, in the nasal 
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mucosa during an in vivo EHV-1 infection, are CD172a-positive mononuclear cells, which are 
either monocytes or dendritic cells, followed by T-lmphocytes and B-lymphocytes (Gryspeerdt et 
al., 2010). The study of Vandekerckhove et al., (2010) using the respiratory mucosa explants 
showed that monocytic cells (CD172a+ cells) are the main targets followed by T-lymphocytes. 
Other studies on the replication in peripheral blood mononuclear cells have shown that EHV-1 
replication is predominantly found in monocytes and B-lymphocytes after in vitro infection of 
PBMC (Yeo et al., 2013; Ma et al., 2010; Goodman et al., 2007). Van der Meulen and colleagues 
(2000) indicated that only 0.9 % of equine lymphocytes were infected with EHV-1 and less than 
0.05 % produced infectious virus.  
 
Latency 
After an initial infection of respiratory epithelial cells, EHV-1 enters a latent state in sensory nerve-
cell bodies within the trigeminal ganglia and in leukocytes (Allen et al., 2004). In latently infected 
horses, reactivation is followed by a shedding of the virus in nasal secretions and reoccurrence of 
viremia has been triggered by immune suppression upon administration of corticosteroids (Slater 
et al., 1994). Reactivation of a latent virus results in spreading of EHV-1 to susceptible animals 
which plays a crucial role in the epidemiology of this virus (Gibson et al., 1992; Edington et al., 
1886). During latency, the expression of the EHV-1 genome is repressed and only a viral RNA 
transcribed from the immediate early (IE) gene, which is also named latency associated transcript 
(LAT), is present (Paillot et al., 2008). Detection of latent EHV-1 is possible by prolonged co-
cultivation of permissive cells together with cells collected from blood, draining lymph nodes of 
the respiratory tract and trigeminal ganglia (Allen et al., 2004). The molecular mechanism by 
which EHV-1 enters into a latent relationship with its equine host cell is still not clear. 
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2.4. EHV-1 associated diseases 
 
Respiratory disease 
Infection of horses with EHV-1 results primarily in upper respiratory tract diseases such as 
rhinopharyngitis and tracheobronchitis (Allen et al., 2004). Young horses usually develop fever, 
serous to mucopurulent nasal discharge and swelling of draining lymph nodes, while older horses 
mainly show mild or subclinical disease (Coggins, 1979). In sporadically reported cases, EHV1 
targets the pulmonary endothelium in young horses, which causes a severe pulmonary edema (Del 
Piero and Wilkins, 2001; Del Piero et al., 2000). Such severely affected horses may die in acute 
respiratory distress. 
 
Abortion and neonatal syndrome 
EHV-1 is considered as one of the most important infectious causes of abortion worldwide in 
horses (Leblanc, 1999). After cell-associated viremia, EHV-1 reaches endothelia in target organs, 
the uterus of a pregnant mare and the central nervous system. Adhesion molecules in endothelial 
cells of the pregnant uterus play an important role in the infection and are upregulated during an 
EHV-1 infection (Patel and Heldens, 2005). Widespread infection of endometrial blood vessels of 
the uterus leads to severe vasculitis and multifocal thrombosis, resulting in an abortion (Patel and 
Heldens, 2005). The period between infection and abortion differs from 9 days to 4 months but 
most mares abort within 21 days (Powell, 1991). During the last 4 months of pregnancy, there is a 
much higher chance (up until 95%) of abortion (Allen and Bryans, 1986).  
 
Nervous system disorders 
Several alphaherpesviruses, such as HSV-1, BoHV-1 and PRV are considered neurotropic viruses, 
being able to cause encephalitis by viral replication in neurons. However, EHV-1 does not cause 
myeloencephalitis by a specific neurotropism, but rather a marked endotheliotropism (Edington et 
al., 1986; Whitwell and Blunden, 1992; Wilson, 1997). Therefore, secondary replication of EHV1 
in the endothelial cells of blood vessels of the nervous system is the first step in the development 
of nervous system disorders (Edington et al., 1986). All parts of the central nervous system may 
be affected by EHV-1.  
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3. Trafficking of leukocytes - Recirculation of leukocyte  
 
EHV-1 is hijacking leukocytes in the respiratory tract in order to invade and to be transported via 
blood to internal target organs, such as the pregnant uterus and central nervous system. At present, 
it is not known how the virus is doing this. It could be that the leukocytes are just driven by a 
physiological process. However, it is also possible that the virus is taking over the migration of the 
virus for its own benefit. These important questions in the pathogenesis will be considered in the 
present PhD thesis. In this context, a good knowledge of cell trafficking is helpful in interpreting 
the results.  
Cell trafficking is regulated by complex and heterogeneous mechanisms and is involved in a 
multitude of physiological as well as pathological processes, including embryogenesis, tumor 
metastasis, tissue formation, wound healing, and immune responses. In general, the migration of 
cells over substrata is a dynamic process that implies multiple steps (usually a five-step cycle) in 
which each “step” occurs simultaneously: (1) protrusion of the leading edge; (2) adhesion to the 
substrate; (3) contraction of the cytoplasm; (4) release from contact sites; and (5) recycling of 
membrane receptors from the trailing to the leading edge (Sheetz et al., 1999). Each step is 
regulated and mediated by one or more cyclical biochemical processes. Different cell types can 
adopt a variety of migration modes, which are commonly categorized on the basis of dynamics 
and the structure of the leading edge, and the underlying cytoskeletal organization (Friedl and 
Wolf, 2010; Weninger et al., 2014). Leukocytes are scattered throughout the body and have the 
potential to infiltrate any type of tissue. Their migration is integral to their function and is 
maintained throughout their life span. The mechanisms of leukocyte migration are essentially 
different from those of other cell types (Renkawitz and Sixt, 2010). Leukocytes use a migration 
mode (quick and frequent change in shape) that is classically termed “amoeboid” (Lämmermann 
and Sixt, 2009; Lämmermann et al., 2008). Indeed, this migration is induced by a variety of 
signaling mechanisms that receive and process information from the leukocyte environment and 
provides specific control of cytoskeletal and adhesion machineries within the cell (Petrie et al., 
2009; Weninger et al., 2014). The adhesion of cells to the substratum is mediated largely by 
members of the selectin and integrin families (Ridley et al., 2003; Sheetz et al., 1998).  
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Some leukocytes (mainly monocytic cells) leave the blood circulation, differentiate into 
macrophages or DCs and patrol healthy tissues, including the mucosal epithelium of the respiratory 
tract (Imhof and Aurrand-Lions, 2004; Auffray et al., 2007; Yang et al., 2014; Randolph et al., 
1999). A subset of monocytic cells (mainly DCs) capture antigens, and recirculate afterwards. 
They transport the antigens to the draining lymph nodes and blood circulation and present them to 
the immune system (Auffray et al., 2007; Jakubzick et al., 2013). Recirculation of monocytic cells 
is playing an important role in the pathogenesis of a generalized EHV-1 infection.  
Leukocyte recirculation means that leukocytes leave the bloodstream and migrate through the 
tissues, where they fulfill their task as immune cells, and return to the bloodstream directly via 
capillaries or via efferent lymphatic vessels. They rapidly adapt their cell shape and migratory 
machinery to the different conditions of the microenvironment, which enables them to effectively 
traverse interstitial spaces at high speed. In general, the recruitment of leukocytes from the 
vasculature into tissues is fairly similar for the different leukocyte subpopulations (Chavakis et al., 
2009). This extravasation process requires a complex cascade of adhesive events between the 
leukocytes and the endothelium including: (I) the initial selectin-dependent rolling and tethering 
of the leukocytes, (II) the chemokine-induced leukocyte activation, (III) the integrin-mediated firm 
adhesion and (IV) the transendothelial migration of leukocytes, which can take place in both a 
paracellular and a transcellular manner. Each of these steps (capture, rolling, slow rolling, firm 
adhesion and transmigration) appears to be necessary for effective leukocyte recruitment 
(Chavakis et al., 2009; Schmidt et al., 2013).  
Leukocyte recruitment initiates with the capture of free flowing leukocytes and their subsequent 
rolling along the vessel wall. This is followed by firm leukocyte arrest, post-arrest modifications 
such as adhesion strengthening and intraluminal crawling, and finally transmigration into tissue. 
The initial attachment and rolling steps are initiated by interactions of endothelial E- and P-
selectins and their counter receptors on leukocytes. The rolling step is reversible, unless followed 
by endothelial-presented chemoattractants and/or chemokines that activate leukocyte α4β1 (also 
called VLA4) and two members of the β2 integrin family, namely lymphocyte function-associated 
antigen 1 (LFA-1) and macrophage-1 antigen (Mac-1), to cause leukocyte arrest by binding to 
their cognate ligands, vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion 
molecule-1 (ICAM-1), respectively (Leick et al., 2014). A detailed illustration of the perivascular 
extravasation in leukocyte migration is shown in Figure 6. 
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Figure 6. Schematic representation of the perivascular extravasation unit, consisting of 
endothelial cells, the basement membrane, perivascular macrophages, and mast cells (above). The 
sequential steps in leukocyte emigration are controlled by interactions between specific molecules 
on leukocytes and their counter-receptors on endothelial cells. Following endothelial cell 
activation and the increased expression of P- and E-selectins, low-affinity adhesive interactions 
(capture and rolling) are elicited that subsequently lead to leukocyte activation, followed by firm 
adhesion and transendothelial migration. Confocal image of endothelial cells (blue) with 
perivascular macrophages (green) is shown underneath (Weninger et al., 2014). 
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3.1. Leukocyte rolling and leukocyte activation during tethering 
Leukocyte capture and rolling are mediated by selectins that belong to the C-type lectin family and 
interact with carbohydrate determinants on their ligands in a calcium-dependent manner. P-selectin 
is the primary adhesion molecule for capture and the initiation of leukocyte rolling (Sperandio, 
2006; Schmidt et al., 2013). Inflammatory stimuli induce rapid exposure of P-selectin on the apical 
endothelial surface, which can support both capture and rolling in the absence of L-selectin 
(McEver, 2002). The most important ligand for selectins is P-selectin glycoprotein ligand-1 
(PSGL-1), which is present as a homodimer on leukocytes and can bind to both P-selectin and E-
selectin (Zarbock et al., 2007; Langer and Chavakis, 2009). Once leukocytes are captured, they 
may transiently adhere to the venular endothelium and begin to roll. In addition to promoting the 
initial interaction between activated endothelium and moving leukocytes, selectins might play a 
role in the induction of subsequent endothelial deformation, which would facilitate leukocyte arrest 
and transmigration towards peripheral tissues, and enhance the diffusion of soluble molecules 
between intravascular and peripheral compartments (Kaplanski et al., 1994). The three mentioned 
selectins share a similar structure and are named by the prefixes P (platelet), E (endothelial), and 
L (leukocyte), according to the cell type in which they were originally identified (Kelly et al., 
2007). Several studies engaging antibody blockade of selectins demonstrated the participation of 
those in tethering and rolling of leukocytes. 
 
3.2. Integrins in leukocyte migration 
Integrins and their ligands 
Integrins are a large family of heterodimeric transmembrane glycoproteins that attach cells to 
extracellular matrix (ECM) proteins or to ligands on other cells. Integrins comprise a large (120–
170 kDa) α-subunit and a small (90–100 kDa) β-subunit. Mammalian genomes contain 18 α 
subunit and 8 β subunit genes, and 24 different α-β combinations have been identified at the protein 
level up until now. Although some subunits appear only in a single heterodimer, 12 integrins 
contain the β1 subunit, and 5 contain αV (Humphries et al., 2006; Luo et al., 2007; Plow et al., 
2000; Hynes, 2002). The 24 integrin heterodimers are shown in Figure 7. 
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Figure 7. The integrin receptor family. 18 α subunits combine with 8 β subunits to form 24 distinct 
heterodimers.  Integrin heterodimers on immune cells are shown with red lines (Luo et al., 2007). 
 
Integrins are the important surface adhesion receptors mediating cell-matrix adhesion in metazoan; 
therefore their name denotes their relevance for maintaining the integrity of the cytoskeletal-
extracellular matrix linkage (Berrier and Yamada, 2007). Integrins play a crucial role in a multitude 
of both physiological and pathological processes including cell migration, embryogenesis, 
development, tissue homeostasis, wound healing, leukocyte trafficking, immune responses, 
autoimmune diseases, cancer, and metastasis (Hynes, 2002;  Hynes, 1992). Typical integrins 
include macrophage antigen-1, Mac-1 (αMβ2), leukocyte function–associated antigen 1 (LFA-1 
or αLβ2), and very late antigen 4 (VLA-4 or α4β1). Mac-1 recognizes a more diverse set of ligands, 
including extracellular matrix proteins such as fibrinogen and fibronectin, as well as activated 
complement proteins such as iC3b. The ligands (or counter-receptors) for LFA-1 are the 
intercellular adhesion molecules (ICAMs) 1–5 that are expressed primarily on vascular endothelial 
cells. VLA-4 recognizes the vascular intercellular adhesion molecule (VCAM-1), whereas the 
major integrin on platelets, αIIbβ3, primarily binds fibrinogen (Abram and Lowell, 2009).  
 
Integrin activation 
The expression and activation of integrins are dynamically regulated, based on the activation of 
leukocytes. It has already been shown that integrins can exist in different ligand affinity states - 
low, intermediate and high (Luo et al., 2007). Crystal structures have revealed that integrin 
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heterodimers occur in an inactive, bent V-shape with the head close to the membrane-proximal 
regions of the legs, and are maintained by the α/β salt bridge at the inner membrane region and 
helix packing of the transmembrane region. The low affinity structure undergoes rapid, reversible 
conformational changes to increase ligand affinity, termed "activation" (Calderwood, 2004; Banno 
and Ginsberg, 2008). It is important to notice that leukocyte integrin activation usually takes place 
under blood flow conditions. Circulating leukocytes maintain their integrins in a low-affinity or in 
an inactive state to avoid nonspecific contact with uninflamed vascular walls. When they get to 
the inflammatory site, the chemokine-induced activation mediates a reversible change of the 
conformation of the integrins from the inactive, bent form to the extended form with intermediate 
affinity. This process prepares the integrin for binding to its endothelial ligand. The integrin 
undergoes a subsequent conformational alteration after binding to the ligand (outside-in signaling), 
culminating in the complete activation of the integrin (Barreiro and Sanchez-Madrid, 2009). 
 
3.3. Role of ICAM-1 and VCAM-1 in leukocyte adhesion 
The basis for the preferential binding of leukocytes to venular endothelial cells during 
inflammation, is related to the increased expression of some endothelial cell adhesion molecules 
in venules such as ICAM-1 and VCAM-1. Clustering of ICAM-1 and VCAM-1 on the endothelial 
cell has been observed as the leukocyte approaches the endothelial cell border (Muller, 2011; 
Muller, 2013; van Buul et al., 2010). ICAM-1 (CD54) is expressed on activated endothelial cells, 
high endothelial venules (HEV), T cells, B cells, monocytes/macrophages, granulocytes, and 
dendritic cells. ICAM-1–ligand interactions are involved in leukocyte firm adhesion, emigration 
through engagement with the endothelium, and also in leukocyte–leukocyte aggregation and 
activation (Pluskota and D'Souza, 2000; Kevil, 2003). ICAM-1 is a ligand for LFA-1 and is 
upregulated following inflammatory stimulation.  Mac-1 also binds ICAM-1, however this integrin 
is a fairly promiscuous molecule capable of binding fibrinogen, fibronectin, and complement 
fragments (Diamond et al., 1993).  VCAM-1 (CD106) is expressed on bone marrow stromal cells, 
myeloid progenitors, splenic dendritic cells, activated endothelial cells, as well as some 
lymphocytes. Upregulation of VCAM-1 occurs through de novo synthesis after cytokine 
stimulation (Beekhuizen and van Furth, 1993). Both VCAM-1 and ICAM-1 are involved in firm 
adhesion of leukocytes, to the apical surface of endothelial cells, through interactions with 
leukocyte integrins (Barreiro et al., 2002; Miller et al., 1995; Carman and Springer, 2004). Like 
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for ICAM-1, clustering of VCAM-1 induces intracellular signalling, leading to p38 
phosphorylation, ROS production and protein tyrosine phosphatase 1B activation (van Furth 1993; 
Deem et al., 2007). It has already been indicated that the presence of the tetraspanins CD9 and 
CD151 is needed for optimal adhesive functions of ICAM-1 and VCAM-1 (Barreiro et al., 2005). 
Taken together, binding of leukocytes to either ICAM-1 or VCAM-1 induces multiple effects in 
the endothelium most of which serve to promote the interaction between the leukocyte and the 
endothelium as well as the subsequent transendothelial migration.   
 
3.4. Leukocyte recruitment during inflammation 
Inflammatory responses are the cornerstone of the body’s defense mechanism against viral and 
bacterial pathogens as well as against physically, chemically and environmentally mediated tissue 
and organ damage. This crucial process can protect organisms by removing or neutralizing 
injurious agents. Recruitment of immune cells to sites of infection, immune reaction, or injury is 
complex and involves coordinated adhesive interactions between the leukocyte and the endothelial 
cell monolayer. It is well documented that the endothelium of a vessel wall is actively involved in 
supporting leukocyte transendothelial migration towards the site of inflammation (Springer, 1994; 
Leick et al., 2014). The site of leukocyte recruitment in most tissues is the postcapillary venule 
(Kluger, 2004). After binding of leukocytes to the endothelium, Ig-like cell adhesion molecules 
(CAMs) that are expressed on the apical surface of the endothelium, are clustered, recruited to 
sites of leukocyte adhesion, and concomitantly activated (Kluger, 2004). The main Ig-like CAMs 
on endothelium are inter-cellular adhesion molecule-1 (ICAM-1/CD54) and vascular cell adhesion 
molecule-1 (VCAM-1/CD106).  
 
3.5. Leukocyte migration back to the blood circulation 
Migration of leukocytes from the vascular lumen to the extravascular tissue is a vital component 
of the host’s defence reaction to injury and infection. However, the migration of tissue-resident 
leukocytes (mainly APCs such as DCs) from mucosal tissues towards the blood circulation and 
lymph nodes have never been explored to date and the migration deserves more attention.   
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4. Mucosal immune cells 
 
The mucosal immune cells of the equine respiratory mucosa are not characterized and defined up 
till now. In general, the mucosal surface of the respiratory tract is separated from the external 
environment by the epithelial barrier, which protects it using nonspecific defense mechanisms 
(mechanical cleaning, mucosal secretion, and others). The mucosa-associated lymphoid tissue 
(MALT) provide specific protective mechanism. Nasal-associated lymphoid tissue (NALT) is an 
organized lymphoid aggregated and infiltrated to the overlying epithelium in the nasal cavity. In 
humans, this tissue exists as a so-called diffuse NALT consisting of a collection of isolated 
subepithelial lymphoid follicles (Neutra, 1999; Debertin et al., 2003). The NALT has 
heterogeneous immunocompetent cells, including subepithelial B-lymphocytes, CD4+and CD8+T-
lymphocytes, phagocytic APCs such as macrophages and diverse subsets of DCs. In addition, the 
overlying epithelium of mucosal follicles forms a specialized cell layer (i.e., follicle-associated 
epithelium) that has a loose structure which enables the contact between antigens and immune 
cells (Neutra, 1999; Bienenstock and McDermott, 2005).  
The composition of quine nasal mucosal immune cells and and the susceptibility of these cells to 
an EHV-1 infection, and the effect of an EHV-1 infection on the behavior of these cells (migration 
and immunological response) have never been explored to date. By using the respiratory mucosa 
explants, it has been demonstrated that the majority of EHV-1-infected cells are monocytic cells 
which express surface marker CD172a (Vandekerckhove et al., 2010). CD172a belongs to the 
family of Signal Regulatory Proteins (SIRP) and is typically found on the surface of neurons and 
myeloid cells such as macrophages, DCs, monocytes and granulocytes (Barclay and Brown, 2006; 
Van Beek et al., 2005). Moreover, CD172a has also been described to be expressed on the cell 
surface of human, rat and equine mesenchymal stem cells (Vogel et al., 2003; Rooney et al., 2008; 
Claessen et al., 2015). The expression level of CD172a differs not only among monocyte and DC 
subtypes but also between different tissues (Seiffert et al., 2001; Epardaud et al., 2004; Bimczok 
et al., 2006; Lahoud et al., 2006; Saito et al., 2010). CD172a-positive macrophages are produced 
by differentiation of monocytes and their main function is phagocytosis of cellular debris and 
destroy pathogens. They are found between the epithelium and in the lamina propria of the 
respiratory mucosa (Holt, 1993). Several MHC class II and CD172a-positive DCs are situated 
Introduction 
 
34 
 
within the airway epithelium. DCs form a complex of APCs in the respiratory mucosa (Holt et al., 
1990). DCs of mucosal surfaces are able to act as APCs after migration out of mucosal tissues to 
draining lymph nodes (Hamilton-Easton and Eichelberger, 1995). Upper respiratory mucosal DCs 
are greatly endocytic and one of the best at presenting antigenic peptides to naïve CD4+ 
lymphocytes (von Garnier et al., 2005). The Langerhans cell (LC), probably the most expansively 
studied DC in the nasal mucosa is found in both the epithelial layer and in the lamina propria. 
Immature LCs are very effective in antigen binding and processing, but weak in stimulating resting 
T cells (Romani and Schuler, 1992). Howevere LCs lose their typical characteristics after 
maturation and change their structure, phenotype and functional capacities into those of DCs. The 
DCs function as ‘sensory cells’ of the immune system and identify danger signals. Besides their 
central role in the sensitization against environmental antigens, their ability to activate T cells in 
the airway mucosa allows them to sustain a prolonged inflammation (Huh et al., 2003). Due to 
their ability to take up antigens, their migratory activities and their ability to form close 
associations with T cells, DCs run the risk of becoming infected by and serving as transportation 
for viruses that infect mucosal surfaces such as human immunodeficiency virus (Pope et al., 1994). 
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5. Structure of the basement membrane and connection with 
epithelial cells 
 
One of the crucial steps in the mucosal invasion mechanism of EHV-1 towards the underlying 
lamina propria is the crossing of the basement membrane barrier inside infected leukocytes. Until 
now the mechanism of the EHV-1 penetration process and the effect of the virus on different 
components of the basement membrane is unknown. In the current thesis, research was focused on 
the basement membrane barrier between epithelium and lamina propria and cell surface receptors 
of epithelial cells, integrins, which mediate cell-extracellular matrix adhesion. It is very well 
possible that an infection of EHV-1 in the epithelial cells are inducing changes in the integrin-
anchors and the basement membrane in order to facilitate the passage of leukocytes in the infected 
aria. The basement membrane is a thin layer of a specialized extracellular matrix which encoded 
by a core set of approximately ten highly conserved genes. These genes encode predominantly 
large, insoluble secreted proteins which provide a scaffolding that shapes the basement membrane 
into sheet-like structures between 50 and 100 nm thick along cell surfaces. On electron 
micrographs, the basement membrane appears as electron-dense material in close proximity of the 
basal cell surface of epithelial cells. Conventional fixation results in a dense layer (lamina densa) 
separated from the plasma membrane by a translucent layer (lamina lucida), while a milder method 
of freeze substitution gives a more homogeneous appearance of the basement membrane 
(Hohenester and Yurchenco, 2013, Kelley et al., 2014). Therefore, by electron microscopy of 
glutaraldehyde-fixed and heavy-metal-impregnated thin sections, the basement membrane is 
typically seen as two thin structural layers. The first layer, the basal lamina (lamina basalis), is 
synthesized by epithelial cells and the second layer, the reticular lamina, is produced by fibroblasts. 
The basal lamina is subdivided into a clear lamina lucida directly under the epithelial cells and a 
structurally opaque lamina densa (Evans et al., 1990; Evans et al., 2010).  
More than 50 proteins are known to make up the basement membrane of which the main 
components are: laminins, type IV collagen, nidogen and the heparan sulfate proteoglycans 
(HSPGs), and also often agrin, fibulins, fibronectin and other types of collagen (I, III, V, VI, VII, 
and XVIII) (Erickson and Couchman, 2000; Yurchenco et al., 2004; Yurchenco and Patton, 2009). 
The lamina lucida also contains extracellular proteins of cell adhesion molecules. The main cell 
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adhesion receptors which anchor cells to extracellular matrix and control a multitude of essential 
cellular functions by activating a variety of signaling pathways are integrins. 
In general, the basement membrane separates epithelium, endothelium, peripheral nerve axons, fat 
cells and muscle cells from the surrounding stroma of any given tissue. Polarized epithelial cells, 
such as those in the respiratory tract, constantly remodel the basement membrane by secreting and 
proteolyzing its structural proteins. In turn, basement membrane proteins support epithelial cell-
adhesion, survival and differentiation (Pozzi and Zent, 2011).  
The main components of the basement membrane and the extracellular matrix of the lamina prporia 
are discussed below. A schematic overview of the basement membrane extracellular components 
is given in Figure 8. 
 
 
Figure 8. Schematic representation of the basement membrane (Menter and DuBois, 2012).  
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Laminins 
Laminins are a family of large multidomain, heterotrimeric glycoproteins with molecular weights 
of 500–800 kDa. Sixteen trimeric isoforms have been described in mouse and human tissues, and 
these isoforms vary in their cell and tissue specificity. Each laminin isoform is composed of three 
chains, α, β, and γ, and each isoform exists in five, four, and three genetically distinct forms, 
respectively. Most vertebrates have five α, three γ and three to six β genes (Domogatskaya et al., 
2012). Laminins stick to cells mainly due to the binding of the G domain of the α chains to 
integrins, dystroglycan, sulfated glycolipids or collagen type IV. Laminin molecules also interact 
with other components of the basal membrane matrix and underlying interstitial stroma, and as 
such contribute to the overall makeup. The N-terminal globular domains of the α1 and α2 chains 
as well as the globular domains VI (LN) of the α5 chains can adhere to many different integrin 
isoforms. Laminins contribute to the structure of the extracellular matrix and affect the adhesion, 
differentiation, migration, stability of phenotype, and resistance towards apoptosis of associated 
cells. (Halper and Kjaer, 2014). Due to the fact that a typical basement membrane has the same 
thickness as the dimension of a single laminin molecule, it is hypothesized that it is unlikely that 
laminins are standing erect on the cell surface (Hohenester and Yurchenco, 2013). 
 
Collagens 
Collagens are major proteins of the basement membrane and are certainly the most dominant. 
Years of research have discovered 28 different collagen types, and each type consists of 
homotrimers and heterotrimers that are formed by three polypeptide chains (known as α-chains). 
More than 40 distinct α-chains have been identified in humans as well as several other proteins 
containing domains similar to collagen (Ricard-Blum and Ruggiero, 2005; Mouw et al., 2014).  
Collagens can be categorized into classes based upon their suprastructural organization which are 
shown in Table 3. 
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Table 3. General classification of collagen types (Mienaltowski and Birk, 2014).  
 
Classification  Collagen types Supramolecular structure 
 Fibril-forming collagen I, II, III Striated fibrils  
V, XI Striated fibrils, retain  
N-terminal regulatory 
domains  
XXIV, XXVI Unknown 
 FACIT collagens IX, XII, XIV Associated with fibrils, other  
interactions  
 FACIT-like collagens XVI, XIX, XXI, XXII Interfacial regions, basement  
membrane zones  
 
 Network-forming 
collagens 
 
- Basement membrane IV Chicken wire network with  
lateral association  
- Beaded filament-
forming 
VI Beaded filaments, networks  
- Anchoring fibril VII Laterally associated anti-
parallel  
dimers  
 Hexagonal networks VIII, X Hexagonal lattices 
 Transmembrane collagens XIII, XVII, XXIII, XXV 
Gliomedins, ectodysplasin 
Transmembrane and shed  
soluble ecto-domains  
 Multiplexin collagens  
(Endostatin–XV and -XVIII)  
  
XV, XVIII Basement membranes, 
cleaved  
C-terminal domains influence  
angiogenesis  
 Other molecules with  
collagenous domains 
XXVI, XXVIII Collagenous domains in  
primarily non-collagenous  
molecules  
Acetylcholinesterase, adiponectin, 
C1q, collectins, surfactant protein, 
others  
FACIT: Fibril-associated collagen with interrupted triple helix. 
 
Our research will focused on collagen type IV and the anchoring fibril (collagen type VII) of the 
basement membrane of the respiratory mucosa.  
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Collagen IV - Type IV collagen is the most often occurring element of the basement membrane. 
This typical collagen is also called ‘network-forming collagen’, due to its capacity to self-assembly 
into organized networks. Unlike most collagens, type IV collagen is only found in the basement 
membrane and forms supramolecular networks through a series of complex inter- and 
intramolecular interactions that influence cell adhesion, migration, and differentiation. Collagen 
VI interacts with many extracellular molecules including: collagens I, II, IV, XIV; microfibril-
associated glycoprotein (MAGP-1); perlecan; decorin and biglycan; hyaluronan, heparin and 
fibronectin, as well as integrins and the cell-surface proteoglycan NG2. Based on the tissue- 
localization and large number of potential interactions, collagen VI has been proposed to integrate 
different components of the extracellular matrix, including cells (Ricard-Blum and Ruggiero, 
2005; Mouw et al., 2014). Recent studies indicated that type IV collagen not only represents a 
structural protein providing tissue integrity but also affects the invasive behavior of trophoblast 
cells at the implantation site (Oefner et al., 2015).  
 
Collagen VII - Type VII collagen forms an extended network of anchoring fibrils which consists 
of a central collagenous triple-helical domain flanked by two noncollagenous domains, NC1 and 
NC2. The NC1 domain contains multiple submodules with homology to known adhesive 
molecules including fibronectin type III-like repeats and the A domain of von Willebrand factor.  
NC1 subdomains also interact with other extracellular matrix proteins such as type I collagen and 
laminin-322. These anchoring fibrils are in close contact with hemidesmosome (Leineweber et al., 
2011). 
 
Proteoglycans 
Proteoglycans are biological molecules composed of a specific core protein substituted with 
covalently linked glycosaminoglycan (GAG) chains (Schaefer and Schaefer, 2010). The primary 
biological function of proteoglycans derives from the biochemical and hydrodynamic 
characteristics of the GAG components of the molecules, which bind water to provide hydration 
and compressive resistance. In general, they classified into three major categories: (1) small 
leucine-rich proteoglycans, 2) modular proteoglycans, and 3) cell-surface proteoglycans. Being 
mostly extracellular, they are upstream of many signaling cascades and are capable of affecting 
intracellular phosphorylation events and modulating distinct pathways, including those driven by 
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bone morphogenetic protein/transforming growth factor superfamily members, receptor tyrosine 
kinases, the insulin-like growth factor-I receptor, and Toll-like receptors (Schaefer and Schaefer, 
2010; Mouw et al., 2014). Proteoglycans are characterized by a core protein that is covalently 
linked to GAGs, which are long, negatively charged, linear chains of disaccharide repeats. Major 
GAGs include heparin sulphate, chondroitin sulphate, dermatan sulphate, hyaluronan and keratin 
sulphate. The main heparin sulphate proteoglycan is perlecan which its core protein has binding 
sites for type IV collagen, entactin/nidogen, and integrins (Mouw et al., 2014). 
 
Entactin/nidogen 
Entactin/nidogen accounts for 2 to 3% of the total amount of basement membrane protein. 
Nidogen-1 binds calcium ions and this calcium-binding activity of entactin may play a role in the 
matrix assembly process. Its major function appears to be the assembly of the basement membrane. 
The carboxyl globule binds tightly to one of the short arms of laminin at the inner rodlike segment. 
This same region is also believed to be responsible for the attachment of nidogen-1 to type IV 
collagen at approximately 80 nm from its carboxyl noncollagenous end. Nidogen-1 therefore could 
serve as a bridge between the two most abundant molecules in the basement membrane (Yurchenco 
and O’Rear, 1994; LeBleu et al., 2007). 
 
Integrins  
Integrins are a large family of heterodimeric transmembrane glycoproteins that act in a 
bidirectional fashion and are modulated by the mechanical properties of the cell-extracellular 
matrix interface (more details are discussed in section 3.2. Integrin in leukocyte migration). They 
are expressed on different cell types. Specialized epithelial cells express unique integrin ranges, 
however there are broad similarities in the pattern of integrin expression in most surface epithelia. 
At least seven different integrins are expressed on human airway epithelial cells (Sheppard, 2003). 
On the epithelia, their functions are: epithelial cell anchoring, fibroblast anchoring and leukocyte 
migration and homing. Signals from integrins also play essential roles in virtually every aspect of 
the behavior of epithelial cells, including survival, proliferation, maintenance of polarity, secretory 
differentiation, and malignant transformation (Hynes, 2002; Sheppard, 2003).  
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Equine herpesvirus type 1 (EHV-1) causes respiratory, nervous and reproductive problems in 
horses throughout the world, which lead to serious economic losses. Primary infection of EHV-1 
occurs at the upper respiratory tract (URT) and is followed by a cell-associated viremia, which is 
the prerequisite for infection of endothelial cells of the pregnant uterus and central nervous system 
(CNS). Leukocytes play a crucial role in transporting the virus from the primary sites of replication 
to the internal target organs. It has been well documented that the majority of EHV-1-infected 
leukocytes are of the monocytic lineage. In addition, migration of these immune cells from the 
respiratory mucosa to the draining lymph nodes is important for the induction and initiation of 
both innate and adaptive immune responses. 
  
The mucosal surface of the respiratory tract represents an important site of entry for a vast majority 
of pathogens and viruses in particular. Professional antigen presenting cells (APCs), such as 
dendritic cells (DCs) and monocytes/macrophages are a key factor in inducing primary immune 
responses against invasive pathogens. Most respiratory viruses restrict their replication to the 
mucosal epithelial cells, however some viruses such as EHV-1 are able to breach the basement 
membrane (BM) barrier by hijacking mononuclear immune cells.  
 
The present study was designed to isolate and characterize mucosal monocytic cells in the 
respiratory mucosa (Chapter 3.1) and to compare their migration patterns with those of blood-
derived monocytic cells and monocyte-derived DCs in nasal mucosal explants. Afterwards, the 
effect of EHV-1 infection on the migratory behavior of these three monocytic cell types in nasal 
mucosa was investigated (Chapter 3.2). In addition, the impact of an EHV1 infection on integrin 
alpha 6 and different components of the basement membrane (laminin, collagen IV and collagen 
VII) was examined in order to determine whether a mucosal EHV-1 infection may disrupt the 
barrier function of the underlying basement membrane (Chapter 4).  
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A. Isolation and Characterization of Equine Nasal Mucosal 
CD172a+ Cells 
Hossein Bannazadeh Baghi, Kathlyn Laval, Herman Favoreel, Hans J. Nauwynck 
Veterinary Immunology and Immunopathology, 157,155–63, (2014) 
Summary  
The nasal mucosa surface is continuously confronted with a broad variety of environmental 
antigens, ranging from harmless agents to potentially harmful pathogens. This area is under 
rigorous control of professional antigen presenting cells (APCs), such as dendritic cells (DCs) and 
macrophages. Mucosal APCs play a crucial role in inducing primary immune responses and the 
establishment of an immunological memory.  
In the present study, a detailed characterization of CD172a+ cells, containing the APCs residing in 
the equine nasal mucosa was performed for the first time. CD172a+ cells were isolated from 
collagenase-treated equine nasal mucosa fragments by MACS. Expression of surface markers was 
determined by flow cytometry and functional analysis was done by measuring the uptake of FITC 
conjugated ovalbumin (FITC-OVA). Cell surface phenotype of the isolated cells was as follows: 
90% CD172a+, 30% CD1c+, 46% CD83+, 42% CD206+ and 28% MHC II+. This clearly differs 
from the phenotype of blood-derived monocytes: 96% CD172a+, 4% CD1c+, 11% CD83+, 9% 
CD206+, 72% MHC II+ and blood monocyte derived DCs: 99% CD172a+, 13% CD1c+, 30% 
CD83+, 51% CD206+ and 93% MHC II+. The CD172a+ nasal mucosal cells were functionally able 
to endocytose FITC-OVA but to a lesser degree than monocyte-derived DCs.  
Together, these results demonstrate that the isolated CD172a+ nasal mucosal cells resemble 
immature DCs in the nasal area. 
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1. Introduction 
Dendritic cells (DCs), scattered throughout the peripheral tissues, act as sentinel cells and 
recognize a wide range of microorganisms. When pathogen invasion takes place, these still 
immature DCs (iDCs) can capture microorganisms via endocytic surveillance receptors, resulting 
in the classical intracellular lytic pathway that permits processing of antigenic peptides. 
Subsequently, the DC mature and migrate from tissue to the draining lymph node to present 
antigens to T-cells (Steinman, 1991). The DC subtype, immunological microenvironment and 
activation state determine the nature of the adaptive immune response produced, including a 
variety of effector responses, anergy or tolerance. The pivotal role of DCs in directing the immune 
response has generated great interest in DC biology and its relevance to many aspects of infection 
and immunity (Steinman and Banchereau, 2007). 
It has already been shown that DCs are present at all mucosal surfaces throughout the body 
(Iwasaki, 2007). They are constantly exposed to both harmful and benign factors in contact with 
the mucosa (Długońska and Grzybowski, 2012; Soloff and Barratt-Boyes, 2010). Their role at 
these sites is to initiate and regulate innate immune responses, acquire foreign antigens, and present 
antigens in mucosa-associated lymphoid tissues (MALT) such as GALT (gut-associated lymphoid 
tissue), NALT (nasopharynx- or nose-associated lymphoid tissue), LALT (larynx-associated 
lymphoid tissue), BALT (bronchus-associated lymphoid tissue), and GENALT (genital-associated 
lymphoid tissue).  
As the most potent antigen-presenting cell, DCs link the innate and adaptive immune responses 
after microbial infection. Mucosal DCs are specialized in inducing a local IgA response, which is 
extremely important in protecting the area exposed to the outer world. In horses, some pathogenic 
microorganisms such as alphaherpesviruses and arteriviruses are known to hijack mucosal 
monocytic cells and, by doing so, to invade the nasal mucosa (Vandekerckhove et al., 2011; Vairo 
et al., 2012). A clear understanding of the immunobiology of mucosal DC infection in the upper 
respiratory tract and how DCs are manipulated by viruses are therefore critical for designing 
effective prevention strategies for viruses that use the upper respiratory tract to enter the body not 
only in humans but also in domestic animals like the horse. 
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Cultivation and characterization of equine blood DCs in terms of morphology and function were 
first described in 1997, based on protocols used in humans (Siedek et al., 1997). Later on, in vitro 
differentiation of blood monocytes into DCs was accomplished using recombinant equine IL-4 
and recombinant equine granulocyte macrophage colony stimulating factor (GM-CSF) (Mauel et 
al., 2006). The isolation of equine nasal mucosal DCs and their characterization have not been 
reported yet. Even nasal mucosal DCs in humans are still poorly understood (Allam et al., 2006; 
Faith et al., 2005). 
In this report, we describe a novel technique to isolate nasal mucosal CD172a+ cells from nasal 
mucosa. Phenotypical and functional characterization indicates that this cell population mainly 
consist of immature DC. This new technology will allow us to study the immunobiology of 
primary nasal mucosal APCs and to get a better insight in the intriguing interplay between viruses 
and this important cell population. 
2. Materials and methods 
2.1. Animals and nasal tissue collection 
Nasal mucosae were collected from five horses at the slaughterhouse. Horses negative for 
nasal/ocular discharge and lung pathology were selected. All horses were between 4 and 7 years 
old, as determined by inspection of the dental incisive architecture (Muylle et al., 1996). For blood 
isolation, healthy horses were selected at the Faculty of Veterinary Medicine (Ghent University, 
Belgium). The experiments were authorized and supervised by the Ethical and Animal Welfare 
Committee of the Faculty of Veterinary Medicine of Ghent University (approval nr. 2013/007). 
Collection of nasal mucosae was performed with minor modifications as described previously 
(Vandekerckhove et al., 2009). In brief, mucosal tissues from the deep intranasal part of the septum 
were collected. The tissues were transported in phosphate-buffered saline (PBS), supplemented 
with 1 µg/ml gentamicin (Gibco), 1 mg/ml streptomycin (Certa), 1000 U/ml penicillin (Continental 
Pharma), 5 µg/ml fungizone (Bristol-Myers Squibb), and 10% fetal calf serum to the laboratory. 
To avoid spontaneous migration of DCs, the tissues were kept on ice during transport. Nasal tissues 
were cut into strips of about 2 × 6 cm. For removing residual blood, the tissue fragments were 
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thoroughly rinsed with subsequently CMF-PBS (calcium magnesium free phosphate buffered 
saline) and RPMI-1640. 
2.2. Preparation of single cell suspension from nasal tissues  
The nasal tissues were chopped into 3mm2 and then transferred to a bottle containing CMF-PBS, 
5% FCS, 1 µg/ml gentamycin, 1 mg/ml streptomycin, 1000 U/ml penicillin and 10mM EDTA 
(VWR BDH Prolabo) and incubated at 37°C for 30 min while shaking at 250 rpm (Unimax 2010, 
Heidolph Brinkmann, Germany).  Tissues were then transferred to new beakers containing CMF-
PBS, 5% FCS, 1 µg/ml gentamycin (Gibco), 0.1 mg/ml streptomycin (Certa) and 100 U/ml 
penicillin (Continental Pharma), 30µg/ml DNase I (Sigma-Aldrich), collagenase type IV 
(220U/ml, Gibco, USA) and incubated for 2 hours at 37°C on a shaker platform (Unimax 2010, 
Heidolph Brinkmann, Germany). The supernatant from digests was centrifuged at 4°C for 10min 
at 300×g, and the cell pellet was re-suspended in PBS. A cell strainer with a pore size of 40µm 
(BD Biosciences, San Jose, CA) was used for obtaining a uniform single cell suspension. The 
suspension was layered over Ficoll-Paque™ PLUS gradient (density 1.077; GE Healthcare, Life 
Sciences) and the interface cell layer was then collected and washed three times with CMF-PBS. 
The single cell suspension was kept on ice until MACS separation and flow cytometery analysis. 
2.3. Purification of nasal mucosal CD172a+ cells by MACS  
After digestion, single cell populations were stained with anti-CD172a mAb (Tumas et al., 1994) 
and then positive cells were selected with anti-mouse IgG beads. (Miltenyi Biotech Ltd). For 
MACS preparation, first mouse monoclonal anti-CD172a (VMRD, clone DH59B, 1:100, IgG1) 
was added to the isolated nasal mucosal cells and after incubation during 20 min at 4°C, goat anti-
mouse IgG magnetic beads were added according to the manufacturer’s instructions. After 20 min 
incubation at 4°C, cells were washed and passed over a MACS column. Positively selected cells 
were isolated and suspended in RPMI-1640 containing 10% fetal calf serum (FCS), 1 µg/ml 
gentamycin, 0.1 mg/ml streptomycin and 100 U/ml penicillin and then cultured in 6 well plates for 
6 days. 
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2.4. PBMC isolation and DC generation 
As a control population, equine blood-derived monocytes and monocyte derived DCs were 
prepared with minor modifications as previously described (Dietze et al., 2008). Briefly, 
monocytes were isolated from 50 ml heparinized-blood (100µl heparin). Blood was diluted 1 in 1 
with cold CMF-PBS and layered onto Ficoll-Paque™ PLUS gradient (density 1.077; GE 
Healthcare, Life Sciences), then centrifuged at RT for 30 min at 2100 rpm. The PBMC interface 
was washed twice in phosphate-buffered saline and resuspended in RPMI-1640 containing 10% 
fetal calf serum (FCS), 1 µg/ml gentamycin, 0.1 mg/ml streptomycin, 100 U/ml penicillin. Cells 
were cultured at 37°C in 5% CO2 for 1-2 hours. Non-adherent cells were removed from the plate 
and cultured in new dishes for subsequent adherence of monocytes. The adherent monocytes were 
kept in RPMI-1640 with 10% FCS, 1 µg/ml gentamycin, 0.1 mg/ml streptomycin, 100 U/ml 
penicillin for 24 hours. Monocyte derived DCs were obtained by adding recombinant equine GM-
CSF (Kingfisher Biotech, USA) and IL-4 (R&D Systems, UK) at concentrations of 20 ng/ml and 
10 ng/ml, respectively. After 2 days, the medium was replaced by new cytokine-containing 
medium. All cells were collected by accutase detachment solution (Sigma-Aldrich), counted and 
analysed for their viability by flow cytometry using propidium iodide. 
2.5. Immunophenotyping by flow cytometry 
Immunophenotyping of equine monocyte derived DCs and equine nasal mucosal CD172a+ cells 
were performed by membrane immunofluorescence staining of cell markers. 1-5×105 cells were 
used per marker. The following primary antibodies (Abs) were enclosed: mouse monoclonal anti-
human CD1c (Biolegend, clone L161, 1:50, IgG1), mouse monoclonal anti-human CD83 
(Biolegend, clone HB15e, 1:50, IgG1), mouse monoclonal anti-CD172a (VMRD, clone DH59B, 
1:100, IgG1), mouse monoclonal anti-human CD206 (Biolegend, clone 15.2, 1:50, IgG1), and 
mouse monoclonal anti-equine MHC Class II  (Novus Biological, clone CVS20, 1:100, IgG1) and 
an appropriate isotype-matched control (IgG1) mouse monoclonal anti-PRV gD antibody 13D12 
(Nauwynck and Pensaert., 1995). FITC-labelled goat anti-mouse IgG1 (Immunotech) were used 
as secondary antibody. At least 10,000 cells were analysed using a FACS Canto flow cytometer 
(Becton Dickinson Immunocytometry systems). The data were further analysed with the FACS 
Diva software.  
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2.6. Antigen uptake 
There is a variety of endocytic routes that can be used by DCs to take up antigens (Werling et al., 
1999; Michalek et al., 1991). To examine the endocytic abilities of the different nasal cell 
populations in this study, FITC conjugated ovalbumin (FITC-OVA; Molecular Probes, Eugene) 
was used. The uptake of this tracer molecule was examined using the methodology described by 
Werling et al. (1999). Cells were harvested from equine nasal mucosa as mentioned above. After 
incubation of 1×105cell/ml with FITC-OVA (1 mg/ml) for 1 hour at 37°C, uptake was quantified 
as mean fluorescence intensity (MFI). Background FITC signal was assessed by incubating cells 
in FITC-OVA at 4°C. This value was subtracted from the value measured at 37°C. All incubations 
were performed in PBS-5% FCS. 10,000 events were acquired for each sample using a flow 
cytometer (Becton Dickinson Immunocytometery systems). To verify that the flow cytometry-
based FITC signal represented internalized OVA, cells were also analysed by confocal 
fluorescence microscopy. 
2.7. Statistical analysis 
We designed an experiment to compare FITC-OVA uptake in nasal mucosal cells and peripheral 
blood mononuclear cells, and to analyse the response of these cells and subpopulations after 
treatment with IL-4/GM-CSF and LPS. To this end, an experiment studying three factors (cell 
type, subpopulations and stimulators) in completely randomized design (CRD) with four replicates 
was carried out. Duncan's multiple range tests were used to compare the means. Freshly isolated 
and two days cultured nasal mucosal cells were compared using an unpaired two-tailed Student’s 
t-test. P values equal or lower than 0.05 were considered to be statistically significant. All statistical 
analyses were carried out using SAS 9.2 (SAS Institute Inc., Cary, NC, USA). 
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3. Results 
3.1. Isolation of nasal mucosal CD172a+ cells by magnetic-activated cell sorting 
CD172a+ cells were isolated from equine nasal mucosal cell suspensions by magnetic cell sorting 
after CD172a labeling. To obtain a sufficient purity of enriched cells, the concentration of CD172a 
antibodies (VMRD, clone DH59B, 1:100, IgG1), anti-mouse IgG microbeads (20µl per 107cells) 
and the type of separation column (LS, MidiMACS) were optimized. The number of cells that 
were obtained after collagenase treatment (220U/ml) of two strips (2 × 6 cm) in 20ml was 
approximately 7×107cells/ml. MACS resulted in 2×107 CD172a+cells and 5×107 CD172a- cells. 
This methodology led to a purity of > 90% CD172a+ positive cells and a viability of > 85 %. 
 
Figure 1. Monocyte-derived dendritic cells and equine nasal mucosal CD172a+ cells. Peripheral 
blood mononuclear cells were incubated for 2 hours at 37 °C. The non-adherent cells were washed 
away and the adherent cells were cultured for five days in the presence of rEq GM-CSF (20 ng/ml) 
and rEq IL-4 (10 ng/ml). Equine nasal mucosal CD172a+ cells were isolated from nasal mucosa 
by digestion and magnetic activated cell sorting and cultured for five days without cytokines. Scale 
bar: 20 µm. 
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3.2 Morphology of equine nasal mucosal CD172a+ cells 
The morphology of the equine nasal mucosal CD172a+ cells was examined by means of light 
microscopy during a period of five days (Figure 1). Light microscopy was used to calculate cell 
numbers and to determine viability (trypan-blue staining of dead cells). Cultures showed large 
elongated cells extending their dendrites onto the plastic after 24 hours. After 72 hours, the cells 
became more round to triangular and almost always contained vacuoles and prominent 
pseudopodia. Although cells varied in size and shape, each cell had numerous dendrites which 
were spread in all directions. Interestingly, most of the CD172a+ cells were moving slowly during 
the first 2 days of culture. Afterwards, they were crawling more actively using dendrites and 
pseudopodia up till 3-4 days (Videos 1 and 2). After 5 days, most of them were attached to the 
culture dish.  
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Figure 2. Flow cytometric analysis of equine blood-derived monocytes, monocyte derived 
dendritic cells, equine nasal mucosal cells and CD172a+ positive and negative subpopulation (A). 
Forward and side scatter characteristics of nasal mucosal cells and histogram of propidum iodide 
which is excluded as dead cells (B). Light grey filled histograms illustrate isotype-matched 
controls. The data shown are representative from five different horses.  
3.3. Phenotyping of equine nasal mucosal CD172a+ cells 
Antibodies against the DC markers CD1c, CD83, CD172a, CD206 and MHC II were used to 
characterize equine nasal mucosal CD172a+ cells (Figure 2). The expression of CD172a has been 
used to identify DC subsets in many mammalian species (Milling et al., 2010). Isolation of nasal 
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mucosal cells by magnetic-activated cell sorting with anti-CD172a antibodies resulted in a purity 
that was higher than 90%. The markers CD1c, CD83, CD206 and MHC II were expressed on 30%, 
46%, 42% and 28% of nasal mucosal cells, respectively. As a point of comparison, equine fresh 
blood-derived monocytes and blood monocyte derived DCs were included. The phenotype of 
blood-derived monocytes was 96% CD172a+, 4% CD1c+, 11% CD83+, 9% CD206+, 72% MHC 
II+ and of monocyte derived DCs was 99% CD172a+, 13% CD1c+, 30% CD83+, 51% CD206+ and 
93% MHC II+. Both blood-derived populations were clearly different from the isolated nasal 
mucosal CD172a+ cells. The expression of CD1c and CD83 were considerably higher in CD172a+ 
cells compared with blood-derived monocytes and blood monocyte derived DCs whereas CD206 
was expressed at the same level in CD172a+ cells and monocyte derived DCs. Furthermore, the 
MHC II expression was lower in CD172a+ cells than in both blood-derived monocytes and blood 
monocyte derived DCs.  
3.4. Functional characterization   
The ability of immature DCs to take up antigens in the nasal mucosa is crucial for generating an 
immune response to invading pathogens. Several pathways exist for antigen uptake. FITC-OVA 
is generally used as a measure for receptor-mediated endocytosis. The FITC-OVA model antigen 
is preferentially internalized by macropinocytosis (Lutz et al., 1997), which has been described as 
the most efficient way of soluble antigen internalization (Mc Ever, 1992). To evaluate endocytic 
activity of nasal mucosal cells, either freshly isolated or after cultivation, the uptake of FITC-OVA 
was measured in newly isolated cells and after culturing two days (Figure 3). There was no 
significant difference between fresh and two days old nasal mucosal cells. In CD172a+ cells, the 
uptake was three times higher than in CD172a- cells. To compare the isolated nasal mucosal cells 
with another well-characterized population of leukocytes containing DCs, equine blood 
mononuclear cells were enclosed. Both populations were treated for two days with eqIL-4 
(10ng/ml) / eqGM-CSF (20ng/ml), two well-known DC differentiation factors, and/or 12 hours 
with LPS (1µg/ml), a well-known DC activation factor (Figure 4). The ability to take up FITC-
OVA increased in all cells when treated with eqIL-4 / eqGM-CSF. This increase was significant 
in CD172a+ positive cells.  Cells activated with LPS decreased their ability of antigen uptake, 
especially in nasal mucosa CD172a+ cells. 
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Figure 3. Effect of aging on uptake of FITC ovalbumin (FITC-OVA) in isolated equine nasal 
mucosal cells.  Nasal mucosal cells were adjusted to a concentration of 1×105 cells per ml and 
incubated with FITC-OVA (1mg/ml) for 1 hour at 37°C or 4°C. Mean fluorescence intensity (MFI) 
= MFI (37°C) - MFI (4°C). Statistical analysis for comparison between freshly isolated cells and 
after culturing two days was performed using unpaired two-tailed Student's t-test. The data shown 
are representative for three different experiments. ns: non significant. 
 
 
Figure 4. Comparison of FITC-OVA uptake in three subpopulations of equine peripheral blood 
mononuclear cells and equine nasal mucosal cells. All cells were cultivated with or without eq IL-
4 (10ng/ml) & eq GM-CSF (20ng/ml) for two days and stimulated with or without LPS (1µg/ml) 
for 12 hours. Then, adjusted to a concentration of 1×105 cells per ml and incubated with FITC-
OVA for 1h at 37°C or 4°C. Mean fluorescence intensity (MFI) = MFI (37°C) - MFI (4°C). Error 
bars represent standard deviations (SD). Values above columns followed by the same letter are 
not significantly different (P ˃ 0.05) using the Duncan test. The data shown are representative for 
four different experiments. 
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4. Discussion 
The nose of a horse is the entry site for a large variety of airborne antigens, including a range of 
infectious microorganisms, especially viruses such as equine herpesvirus 1 (EHV-1) and equine 
arteritis virus (EAV) (Gryspeerdt et al., 2010; Vandekerckhove et al., 2011; Vairo et al., 2012). 
Both EHV-1 and EAV have a tropism for nasal mucosal leukocytes (CD172a+ cells and T-
lymphocytes) and misuse these cells for viral transport through the basement membrane (BM) 
barrier (Vairo et al., 2013; Gryspeerdt et al., 2010). Within this mucosal environment, DC play a 
pivotal role by initiation and modulation of immune responses via sampling and presenting 
peptides in an immunogenic form to the adaptive immune system.  
In large animals, the nasal mucosal immune cells have not been well-characterized. In the present 
study, a new methodology consisting of a combination of collagenase digestion and MACS was 
developed to isolate equine nasal mucosal CD172a+ cells and to characterize them by 
morphological analysis, phenotyping and functional testing.  
CD172a is a transmembrane regulatory protein expressed primarily by myeloid cells such as 
macrophages, DCs, monocytes and granulocytes (Barclay and Brown, 2006; Van Beek et al., 
2005). The expression level of CD172a differs not only among DC subtypes but also between 
different tissues (Seiffert et al., 2001; Epardaud et al., 2004;  Bimczok et al., 2005; Bimczok et al., 
2006; Lahoud et al., 2006; Saito et al., 2010). In pigs, lamina propria DCs in the small intestine 
are mainly CD11b+/CD172a+ whereas DCs present in the trachea mucosa are dominated by 
CD16+/CD11b-/CD172a- populations (Bimczok et al., 2005; Bimczok et al., 2006). It has been also 
reported that CD172a+ DCs are the primary immunogenic DCs that migrate out of tissues to 
promote Th2 responses in draining lymph nodes (Raymond et al., 2009). In the present study, we 
examined the morphology, phenotype and function of horse CD172a+ cells. As comparison, we 
used blood derived DCs generated from peripheral blood monocyte cells using IL-4 and GM-CSF. 
In the past, the morphology of equine monocyte-derived DCs was shown to be veiled cells with 
pseudopodia (Mauel et al., 2006). Enzymatic digestion and CD172a magnetic activated cell sorting 
of equine nasal mucosal cells resulted in a population of cells that exhibited an immature 
phenotype during the first two days of activation but a clear morphological appearance of DCs 
after four days. Temporary cytoplasmic extrusions and various branched protoplasmic extensions 
were observed in the isolated cells, which are typical for DCs.  
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Equine DC and macrophage differentiation markers have been reported and characterized 
previously (Siedek et al., 1997; Mauel et al., 2006; Lunn et al., 1998; Kydd et al., 1994; Ibrahim 
and Steinbach, 2007). Based on the expression of different markers, one of the important 
differences between equine blood monocyte derived DCs and equine nasal mucosal monocytic 
cells was CD1c which is originally classified as a Langerhans cell marker in the epidermis but was 
later on also detected on human nasal mucosal DCs (Faith et al., 2005; Jahnsen et al., 2004; Peiser 
et al., 2003). DCs positive for CD1c are located in both the epithelium and lamina propria of the 
human respiratory tract (Jahnsen et al., 2004). In the present study, the percentage of CD1c+ cells 
was significantly higher in isolated CD172a+ cells from nasal mucosae than in blood monocyte 
derived DCs. The comparable high expression of mannose receptor CD206 in both monocyte 
derived DCs and our isolated nasal mucosal CD172a+ cells illustrated their rather immature nature. 
CD83 is one of the well-known maturation markers on human and murine DCs and is markedly 
up-regulated together with co-stimulatory molecules CD80 and CD86 during DC maturation 
(Zhou and Tedder, 1995; Berchtold et al., 1999). Saalmüller and colleagues have demonstrated 
that antibodies against human CD83 and other markers could be applied to equine DCs (Saalmüller 
et al., 2005). The expression of CD83 in equine nasal mucosa CD172+ cells was somewhat higher 
than immature monocyte derived DCs. In the present investigation, the expression of MHC class 
II on isolated nasal mucosal CD172a+ cells was low. By a double immunofluorescence staining 
for CD172a and MHC II markers on fixed cryosections of nasal mucosa of healthy slaughterhouse 
horses, we confirmed the general lack of MHC II on CD172a+ cells in situ (data not shown). Only 
a small subset of CD172a+ cells within the nasal mucosae expressed MHC II with the majority 
having a low level expression. These findings agree with previous observations done in human 
respiratory mucosa cells (Faith et al., 2005). 
Immature DCs are known to take up antigens via receptor-mediated endocytosis and 
macropinocytosis. Upper airway mucosal DCs are more endocytic than their lung counterparts and 
one of the best at presenting antigenic peptides to naïve CD4+ lymphocytes (von Garnier et al., 
2005). DC maturation leads to the down-regulation of the antigen-uptake machinery, up-regulation 
of adhesion and costimulatory molecules, maturation marker CD83 and peptide-MHC complexes 
as well as the polarization of different T-cell subsets (Banchereau and Steinman, 1998; Berchtold 
et al., 1999). In the present study, we measured endocytic activity of freshly isolated nasal mucosal 
CD172a+ cells and after two days cultivation. Our analysis revealed that nasal mucosal CD172a+ 
Isolation and characterization of equine nasal mucosal CD172a+ cells 
 
70 
 
cells took up three times more antigens than CD172a- cells and culturing did not influence the 
uptake activity. Such high uptake could be due to the immature nature of CD172a+ cells in the 
nasal area.  
It is well documented that professional APCs, notably immature DCs in peripheral tissues, are 
highly endocytic and internalize a wide variety of antigens, whereas mature cells have 
downregulated this activity (Banchereau and Steinman, 1998; Burgdorf et al., 2007; Blum et al., 
2013). DC generated with IL-4/GM-CSF express high levels of MHC class I and II and increase 
the capacity of antigen uptake by macropinocytosis and receptor-mediated endocytosis (Basak et 
al., 2002). In contrast, LPS stimulation decreases the endocytosis activity and activates migration 
of DCs (Anderson et al., 2009; Kamphorst et al., 2010). To identify the effect of differentiation 
and activation for efficient antigen capture and functionality of the cells, we studied the uptake 
capacity of isolated nasal mucosal cells and compared them with peripheral blood mononuclear 
cells. Both populations were treated with IL-4 / GM-CSF and stimulated with LPS. FITC-OVA 
was used as a measure for endocytosis activity of all cell populations. Our results revealed that the 
ability of antigen uptake increased in CD172a+ cells when treated with IL-4 / GM-CSF and 
decreased upon LPS activation. In CD172a+ cells, FITC-OVA uptake was significantly greater 
than CD172a- cells. Therefore, it can be concluded that IL-4 / GM-CSF activated uptake of FITC-
OVA. In contrast, LPS is turning down the antigen uptake in cytokine-treated cells. These findings 
are clearly in agreement with what has been described in human or mice (Ahn and Agrawal, 2005; 
Lutz et al., 1996). Furthermore, we showed that in cytokine differentiated and/or LPS stimulated 
blood monocyte derived CD172a+ cells antigen uptake was always higher than in nasal mucosal 
CD172a+ cells. It looks like nasal mucosal CD172a+ cells under steady-state conditions sample 
much antigens and internalize them without directly expressing them via MHC II (low expression 
level in the present study). These cells resemble immature DCs that are professional antigen 
captures and processors at equine nasal mucosal surfaces and carry their antigens to draining 
lymph nodes in order to initiate innate immune response. However, the precise function of these 
cells in vivo remains to be defined.  
In conclusion, magnetic-activated cell sorting of equine nasal mucosal CD172a+ cells ensures the 
isolation of viable and functionally intact cells that retain their semi-immature state. These cells 
are thus ideal for elucidating the functional and phenotypic properties of mucosal APCs, not only 
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in equine but also in other animals and humans. They offer a unique study ground to elucidate the 
cellular and molecular mechanisms responsible for their differentiation, immunostimulatory 
capabilities, and the migration of these crucially important immune conductors. Our observations 
have significant implications for a better understanding of the initiation of nasal mucosal immune 
responses. Furthermore, the homogeneous and well-defined population of nasal mucosal CD172a+ 
cells obtained with our protocol will be suitable to examine how viruses may hijack these cells 
during invasion and immune evasion. 
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Summary  
The mucosal surfaces are important sites of entry for a majority of pathogens, and viruses in 
particular. The migration of antigen presenting cells (APCs) from the apical side of the mucosal 
epithelium to the lymph node is a key event in the development of mucosal immunity during viral 
infections. However, the mechanism by which viruses utilize the transmigration of these cells to 
invade the mucosa is largely unexplored.  
Here, we establish an ex vivo explant model of monocytic cell transmigration across the nasal 
mucosal epithelium and lamina propria. Equine nasal mucosal CD172a+ cells (nmCD172a+ cells), 
blood-derived monocytes and monocyte-derived DCs (moDCs) were labeled with a fluorescent 
dye and transferred to the apical part of a polarized mucosal explant. Confocal imaging was used 
to monitor the migration patterns of monocytic cells and the effect of equine herpesvirus type 1 
(EHV-1) on their transmigration. We observed that 16-26% of mock-inoculated nmCD172a+ cells 
and moDCs moved into the nasal epithelia, and 1-7% moved further in the lamina propria. The 
migration of EHV-1 inoculated monocytic cells was not increased in these tissues compared to the 
mock-inoculated monocytic cells. Immediate early protein positive (IEP+) cells were observed 
beneath the basement membrane (BM) 48 hours post addition (hpa) of moDCs and nmCD172a+ 
cells, but not blood-derived monocytes. Together, our finding demonstrate that monocytic cells 
may become infected with EHV-1 in the respiratory mucosa and transport the virus from the apical 
side of the epithelium to the lamina propria en route to the lymph and blood circulation. 
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1. Introduction 
Nasal mucosal tissue is heavily populated with immune cells, which are continuously bombarded 
with a flow of foreign antigens and environmental microorganisms. Professional antigen 
presenting cells (APCs), such as dendritic cells (DCs), monocytes/macrophages and B 
lymphocytes, play a crucial role in the recognition of invading pathogens and the initiation of 
mucosal immune responses (Banchereau and Steinman, 1998; Iwasaki, 2007). To induce an 
appropriate immune response, these immune cells must migrate from the apical surface of epithelia 
through the mucosa to the blood and lymph circulation. Important elements affecting immune cell 
distribution, migration and function are cell-cell and cell-fiber interactions via adhesion molecules 
and chemokine receptors and their response to chemokine gradients (Springer, 1990; Parlato et al., 
2001; Weber et al., 2013). The migration of APCs in response to viral infection in mucosal tissue 
and the navigation of infected cells to lymph nodes or blood vessels are driven by a complex 
network of cell signals and interactions. After the virus is exposed to the mucosal epithelium of 
the upper respiratory tract (URT), epithelial cells immediately recognize viruses via pattern 
recognition receptors (PRRs) such as Toll-like receptors (TLRs) and intracellular viral sensors 
(Akira, 2009; Diamond et al., 2000; Medzhitov, 2001). Cytokines and chemokines, which 
orchestrate the migration of blood mononuclear cells or mucosal APCs (m-APCs), are also 
produced during viral infection in the airways (Herold et al., 2006; Vareille et al., 2011; Rudraraju 
et al., 2013). 
Alphaherpesviruses use m-APCs to invade their host (Steukers et al., 2012). Equine herpesvirus 
type 1 (EHV-1) is an example of an invasive virus of the airway mucosa. The mucosa of the URT 
is the primary replication site for EHV-1, similar to other alphaherpesviruses (Kydd et al., 1994; 
Van Maanen, 2002; Gryspeerdt et al., 2010; Vandekerckhove et al., 2010). After initial replication 
in the epithelial cells, EHV-1 can disseminate through the basement membrane (BM) barrier via a 
single infected mononuclear immune cell, which then progresses to the blood vessels of the lamina 
propria and the draining lymph nodes. The virus is detectable in infected m-APCs in equine 
respiratory explants around submucosal venules at 12 hours post inoculation (hpi) (Kydd et al., 
1994; Gryspeerdt et al., 2010; Vandekerckhove et al., 2010). These data suggest that infection with 
the virus may direct the migration of the m-APCs toward the lymph nodes or blood vessels. 
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However, it is not clear whether EHV-1 stimulates the migration of these mucosal monocytic cells 
upon infection or just follows the normal migration of the cells. 
In the present study, different types of monocytic cells (blood-derived monocytes, moDCs and 
nmCD172a+ cells) were placed on top of a polarized nasal mucosal explant and their migration 
through the mucosa was followed over time. The impact of EHV-1 infection on this transmigration 
was examined.  
2. Materials and Methods 
 2.1. Collection of tissues and cells 
Six horses were used in this study, and each horse constituted an experimental unit. For each 
experiment blood and nasal samples were collected from the same horse. The horses were of both 
genders and different ages (3-7 years old). The samples were collected at the slaughterhouse and 
processed as previously described, with minor modification (Bannazadeh Baghi et al., 2014). In 
brief, mucosal tissue from the deep intranasal region of the septum was collected and cut into two 
parts: one was transported to the laboratory in phosphate-buffered saline (PBS), supplemented 
with 1 µg/ml gentamicin (Gibco), 1 mg/ml streptomycin (Certa), 1000 U/ml penicillin (Continental 
Pharma), 5 µg/ml fungizone (Bristol-Myers Squibb) and 10% fetal calf serum and the other was 
transported in the same medium, but without fetal calf serum. To avoid spontaneous migration of 
DCs, the tissues were kept on ice during transport. The tissue that was transported without serum 
was cut into small pieces (approximately 50 mm2) for nasal explant culture. The other sample was 
used to isolate nmCD172a+ cells.  
2.2. Isolation and purification of nmCD172a+ cells 
The nasal tissue that was transported in medium containing 10% fetal calf serum was chopped into 
3 mm2 pieces and transferred into medium supplemented with 10 mM EDTA (VWR BDH 
Prolabo). The sample was incubated at 37°C for 30 minutes with shaking at 250 rpm. Afterwards, 
the nasal tissue was transferred into medium containing 30 µg/ml DNase I (Sigma-Aldrich) and 
collagenase type IV (220 U/ml, Gibco, USA) and incubated for 2 hours at 37°C on a shaking 
platform (Unimax 2010, Heidolph Brinkmann, Germany). The digested cell population was 
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layered over a Ficoll-Paque™ PLUS gradient (density 1.077; GE Healthcare, Life Sciences), and 
the interface cell layer was collected. Next, single cell populations were stained with mouse 
monoclonal anti-CD172a (VMRD, clone DH59B, 1:100, IgG1), and the positive cells were 
selected by performing MACS with anti-mouse IgG magnetic beads (Miltenyi Biotech Ltd). 
Immunophenotyping of equine nasal mucosal CD172a+ cells (nmCD172a+ cells) was performed 
as previously described (Bannazadeh Baghi et al., 2014). The sections were incubated with mouse 
monoclonal anti-CD172a (VMRD, clone DH59B, 1:100, IgG1), followed by FITC-labeled goat 
anti-mouse IgG1 (Immunotech) secondary antibody. The cells were analyzed using a FACS Canto 
flow cytometer (Becton Dickinson Immunocytometry systems). This methodology yielded >90% 
pure nmCD172a+ cells with >85% viability. Purified nmCD172a+ cells were cultured in 6-well 
plates.  
2.3. Monocyte isolation and DC generation 
Equine blood-derived monocytes and monocyte-derived dendritic cells were prepared as 
previously described, with minor modifications (Dietze et al., 2008). Briefly, monocytes were 
isolated from 50 ml heparinized blood (100µl heparin). The blood was diluted 1:1 with cold 
calcium/ magnesium-free phosphate-buffered saline (CMF-PBS), layered onto a Ficoll-Paque™ 
PLUS gradient (density 1.077; GE Healthcare, Life Sciences) and centrifuged at room temperature 
for 30 minutes at 2100 rpm. The PBMC interface was washed twice with phosphate-buffered saline 
and resuspended in RPMI-1640 containing 10% fetal calf serum (FCS), 1 µg/ml gentamycin, 0.1 
mg/ml streptomycin and 100 U/ml penicillin. Cells were cultured at 37°C in 5% CO2 for 1-2 hours. 
Non-adherent cells were removed from the plate, and adherent cells were maintained in RPMI-
1640 medium containing 10% FCS, 1 µg/ml gentamycin, 0.1 mg/ml streptomycin and 100 U/ml 
penicillin for 24 hours. The moDCs were obtained by adding recombinant equine GM-CSF 
(Kingfisher Biotech, USA) and IL-4 (R&D Systems, UK) at concentrations of 20 ng/ml and 10 
ng/ml, respectively. All cells were collected using accutase detachment solution (Sigma-Aldrich) 
and counted, and cell viability was assessed by flow cytometry using propidium iodide. 
 
 
Impact of EHV-1 on migration of monocytic cells through nasal mucosa 
 
80 
 
2.4. Monocyte, moDC and nmCD172a+ cell labeling (Cell TrackerTM CFSE) 
All prepared cells were resuspended in 1 ml Dulbecco’s phosphate-buffered saline (D-PBS) with 
0.1% FCS, and the final cell concentration was brought to 4×105 cells/ml and incubated at 37°C. 
Carboxyfluorescein diacetate succinimidyl ester (CFSE; Molecular Probes, Eugene, OR) was 
reconstituted in dimethylsulfoxide (DMSO; BDH, Toronto) just prior to use. Two microliters of 5 
mM CFSE solution per milliliter of cells was added to obtain a final working concentration of 10 
µM. Cells were incubated for 10 minutes at 37°C, followed by an additional 5 minutes at 4°C. 
Incubation at the lower temperature allows the dye to label the plasma membrane and slows down 
endocytosis, reducing dye localization to cytoplasmic vesicles. After CFSE passively diffuses into 
cells, its acetate groups are cleaved by intracellular esterases to yield a highly fluorescent green 
signal. CFSE-labeled cells were washed (centrifuged 10 minutes at 4ºC at 1250 rpm) twice with 
phosphate-buffered saline (PBS) and divided into two equal aliquots for inoculation with EHV-1 
or mock-inoculation cells. Both populations were kept in fresh 50% DMEM (Invitrogen), 50% 
RPMI 1640 (Invitrogen) serum-free medium supplemented with 1 µg/mL gentamicin, 0.1 mg/mL 
streptomycin and 100 U/mL penicillin. After CFSE labeling, cell viability was above 85%.  
2.5. Inoculation of CFSE-labeled cells with EHV-1 and analysis of infection 
Labeled monocytes, moDCs and nmCD172a+ cells were inoculated with EHV-1 strain 03P37, 
which was isolated from the blood of a paralytic horse in 2003 (van der Meulen et al., 2003; Garré 
et al., 2009). 2×105 of cells were inoculated with 106.5 TCID50 of EHV-1 for 1 hour at 37°C and 
5% CO2. The virus stocks used for inoculation were at the 6th passage: 2 passages in rabbit kidney 
cells (RK13) and 4 subsequent passages in equine embryonic lung cells (EEL). Inoculated cells 
were divided into two aliquots (1×105 cells). One aliquot was used for the migration assay on 
tissue, and the other was loaded onto glass inserts in 24-well culture plates (Nunc A/S) to determine 
the degree of infection. To assess the percentage of infected cells, cells were fixed in 100% 
methanol at -20°C for 20 minutes and subjected to immunofluorescence staining. Consequently, 
cells were incubated for 1 hour at 37°C with a rabbit polyclonal anti-IEP antibody (kindly provided 
by Dr. O’Callaghan, USA, 1:1000) to detect immediate early protein (IEP) expression as an 
infection marker. The percentage of viral-antigen-positive cells was calculated based on 500 cells 
from randomly selected microscopic fields. Non-inoculated cells were included as a control. At 0, 
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24 and 48 hpi, cells were subjected to confocal analysis (Leica TCS SP2 Laser scanning spectral 
confocal system, Leica microsystems GmbH, Wetzlar, Germany). 
2.6. Migration of infected cells in the nasal mucosa 
Nasal explants were cut into 50 mm2 pieces, and each section was placed on 3 ml of agarose (50% 
sterile 3% agarose (low temperature gelling; Sigma) and 50% 2x medium (50% 2x D-MEM/50% 
2x F12)), supplemented with 2 µg/mL gentamicin, 0.2 mg/mL streptomycin and 200 U/mL 
penicillin in a well of a 6-well culture plate with the epithelium facing upwards. Additional agarose 
was added until the lateral surfaces of the mucosa were fully occluded. Afterwards, EHV-1 
inoculated and mock-inoculated CFSE-labeled monocytes, moDCs and nmCD172a+ cells were 
resuspended in RPMI-1640 medium with 5% horse hyperimmune serum (HHS) for 1 hour at 37 C ˚
to remove free viruses. Then, the cells were washed with phosphate-buffered saline (PBS) three 
times and pipetted on to the mucosal explants (1×105 cells per explant). To avoid drying out during 
incubation, the nasal mucosa was covered with a thin film of serum-free medium. Plates were 
incubated for 0, 24 and 48 hours at 37°C with 5% CO2. Explants were collected, embedded in 
methylcellose medium (Methocel® MC, Sigma-Aldrich, St. Louis) and frozen at -70°C. Fifty 10-
µm-thick cryosections from each time point were cut and fixed in methanol at -20°C for 20 
minutes, and monocytic cells were counted (infected and non-infected). The BM of the tissues was 
stained with monoclonal mouse anti-collagen VII antibodies (Sigma-Aldrich, St. Louis, 1:300), 
followed by Texas Red®-labeled goat anti-mouse antibodies (Molecular Probes, 1:100). The nuclei 
were counterstained with Hoechst 33342 (Molecular Probes) for 10 minutes. As a negative control, 
10-µm cryosections of mock-inoculated tissues were stained following the aforementioned 
protocol. Appropriate isotype-matched control antibodies were used to confirm the specificity of 
each antibody.  
2.7. Statistical analysis 
The goal of this experiment was to compare the movement of monocytic cells through the mucosal 
epithelium at 0, 24 and 48 hours post addition and to analyze the effect of EHV-1 infection. To 
this end, a completely randomized design (CRD) with three replicates was carried out. Prior to 
analysis, data were square root transformed according to the number of cells required to satisfy 
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assumptions of the analysis of variance. Orthogonal contrasts were used to compare different time 
points in mock-inoculated and EHV-1 inoculated cells. Duncan's multiple range tests were used to 
compare the means. P values equal to or less than 0.05 were considered statistically significant, 
and all statistical analyses were carried out using SAS 9.2 (SAS Institute Inc., Cary, NC, USA). 
 
Figure 1. Immunofluorescence staining of immediate early protein (IEP) in CFSE-labeled 
nmCD172a+ cells, moDCs and monocytes at 24 (A) and 48 (B) hours post inoculation (hpi). 
Images are representative of three independent experiments. Scale bar: 100 µm. 
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3. Results 
3.1. Extent of EHV-1 infection in monocytic cells 
Different types of monocytic cells were infected at different levels (Table 1). In total, 13±1.5% 
and 10±2.5% of moDCs were infected at 24 and 48 hpi, respectively. The percentage of infected 
nmCD172a+ cells and blood-derived monocytes was slightly lower: 11.5±4.5% and 7±2.5%, and 
9±3% and 5±2.5% at 24 and 48 hpi, respectively (Fig. 1). Non-labeled cells were infected to the 
same degree as labeled cells, demonstrating that CFSE labeling did not influence viral infection.  
Table 1. Percentage of EHV-1-infected (IEP+) cells in different populations of monocytic cells. 
Data represent the mean ± SD of three independent experiments. 
Cell type  % IEP-positive cells  
 At 24 hpi†  At 48 hpi 
Nasal mucosal CD172a+ cells 11.5 ± 4.5  9 ± 3 
Monocyte-derived dendritic cells 13 ± 1.5  10 ± 2.5 
Monocytes 7 ± 2.5  5 ± 2.5 
† hpi = hours post inoculation    
 
3.2. Migration of monocytic cells across the nasal mucosal epithelia toward the submucosa 
To determine whether monocytes, moDCs and nmCD172a+ cells cross the nasal epithelium, 
polarized, agarose-embedded nasal mucosa explants were utilized. To analyze the migratory 
behavior of monocytic cells, CFSE-labeled cells were layered on top of the mucosa, and explants 
were collected at 0, 24 and 48 hours. Afterwards, cryosections were cut and stained for BM and 
cell nuclei. Four regions of interest were defined: A-mucosa surface, B-epithelium, C-basement 
membrane + 50 µm underneath (lamina propria), and D-submucosa (Fig. 2). At 0 hours, cells were 
only observed on top of the mucosa surface. There was no significant difference in the migration 
of cells between the 24- and 48-hour intervals. The number of monocytic cells varied at different 
levels of the nasal explant. A small number (1%-7%) of CFSE-labeled moDCs and nmCD172a+ 
cells were detected in the lamina propria and submucosa, consistent with the assumption that 
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monocytic cells migrate toward the draining lymph and blood vessels in the lamina propria and 
submucosa under steady-state conditions. Blood-derived monocytes labeled with CFSE were not 
observed in the deep layers of the lamina propria and submucosa.  
 
 
Figure 2. A schematic model of the polarized tissue explant system used to study the migration of 
monocytic cells in nasal mucosal explants (A). All cell types (nmCD172a+ cells, moDCs and 
monocytes) were labeled with 10 µM CFSE for 10 min. Then, cells were added to the mucosal 
surfaces of polarized explants at 1×105 cells per explant (50 mm2). After 0-, 24- and 48-hour time 
periods, the tissue explants were fixed and sectioned (B); scale bar: 50 µm. Regions of interest 
were divided into four levels (C); scale bar: 10 µm. Representative confocal photomicrographs 
illustrate the migration of monocytic cells (green) in the epithelium (EP) and lamina propria (LP). 
BM: basement membrane, BV: blood vessel, LV: lymph vessel.  
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Figure 3. Representative fluorescence microscopy images of nasal tissues exposed to EHV-1-
inoculated monocytic cells. Labeled and EHV-1 (strain 03P37) inoculated cells (nmCD172a+ 
cells, moDCs and monocytes) were added to the mucosal surfaces of nasal explants (1×105 cells 
per explant, 50 mm2). After 0, 24 and 48 hours post addition (hpa), the tissue explants were fixed, 
sectioned and stained. Then, the sections were examined for CFSE-labeled cells (green) and for 
IEP (red). EHV-1-infected (IEP+) monocytic cells (CFSE+) were identified by the colocalization 
of red and green (yellow). White lines indicate the border between the lamina propria and the 
mucosal epithelium. Images are representative of explants from three independent horses; original 
scale bar, 50 µm. 
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3.3. EHV-1 infection did not change the migratory behavior of monocytic cells 
To study the migration pattern of EHV-1-infected cells, each cell type was labeled with CFSE 
prior to inoculation. Mock-inoculated labeled cells were included as control. The EHV-1 infection 
status was assessed using IEP. All mock-inoculated (CFSE+ IEP-) and EHV-1 inoculated (CFSE+ 
IEP+ /CFSE+ IEP‒) monocytic cells per zone and time point are shown in Table 2. Both EHV-1-
inoculated and mock-inoculated monocytic cells migrated into the epithelium and lamina propria. 
There was no significant difference in migration between the mock-inoculated and EHV-1-
inoculated cells at 24 or 48 hours. Analysis of the colocalization between CFSE and IEP (CFSE+ 
IEP+) revealed that over 80% of the infected nmCD172a+ cells and moDCs remained on top of the 
epithelium after 24 hours. The percentage of these cells decreased to approximately 70% on the 
surface of the nasal mucosa after 48 hours. More than 85% of the CFSE+ IEP+ blood-derived 
monocytes remained on the surface of the nasal mucosa after 24 and 48 hours. Almost 2% and 9% 
of the EHV-1-infected and CFSE-labeled moDCs penetrated through the BM at 24- and 48-hour 
intervals, while only 0% and 3% of the infected nmCD172a+ cells (CFSE+ IEP+) crossed the BM. 
Infected blood-derived monocytes were never observed under the BM (Fig. 3). The number of 
EHV-1-infected (CFSE+ IEP+) nmCD172a+ cells and moDCs that transmigrated into the nasal 
tissue was significantly (P ˂ 0.05) higher than that of blood-derived monocytes after 48 hours 
(Table 3), suggesting that moDCs and nmCD172a+ cells are better transporters at the mucosal 
epithelium compared to blood monocytes. 
 
Table 3. Comparison of the mean number of EHV-1-infected (CFSE+ IEP+) monocytic cells that 
transmigrated into the nasal tissue after 24 and 48 hpa.   
Cell type Number of CFSE+ IEP+ transmigrated 
cells into the  epithelium at 24hpa 
Number of CFSE+ IEP+ transmigrated 
cells into the  epithelium at 48hpa 
nmCD172a+ cells 2.4894a 2.7462a 
moDCs 2.1838ab 2.5480a 
Monocyte 1.8821b 1.9154b 
Data underwent square root transformation. 
Values within a column followed by different letters are significantly different at the 0.05 level using the Duncan test. 
Values within a column followed by the same letters are not significantly different using the Duncan test.  
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4. Discussion 
Epithelial cells of the respiratory mucosa are the primary target cells for many pathogens, 
especially viruses. The ability of APCs to migrate throughout the mucosal epithelium is a critical 
aspect of their immunological function and could be an essential factor for the mucosal immune 
response against invasive pathogens. These immune cells form a network within mucosal surfaces 
to capture antigens, interact with each other, migrate to the draining lymph node and present 
antigens to T cells (Steinman and Banchereau, 2007). The pathogenesis of equine herpesvirus type 
1 (EHV-1) infection starts with the invasion of the virus into the epithelium of the upper respiratory 
tract (URT) and to deeper tissue to initiate cell-associated viremia. Mucosal APCs (m-APCs) act 
as a “Trojan horse” for the virus because they can migrate through the mucosal epithelium and 
eventually to the circulatory system without being recognized by the immune system (Kydd et al., 
1994; Van Maanen, 2002; Gryspeerdt et al., 2010; Vandekerckhove et al., 2010). The present study 
was designed to evaluate the migration of monocytic cells in the URT and to determine their 
importance for EHV-1 transmigration. To this end, we generated a polarized nasal mucosa explant 
system. Agarose was used to cover the bottom and the lateral edges of the explant, leaving only 
the apical mucosal surface accessible to cell penetration. This system allowed us to study the 
motility of monocytic cells alone and the transmigration of these cells during EHV-1 infection 
within nasal mucosal explants.  
First, we examined the movement of normal, non-virus-inoculated monocytic cells. Second, we 
tracked EHV-1-inoculated monocytic cells in the nasal mucosa to assess the effect of infection on 
the migratory behavior of these cells. At 0 hours, the three monocytic cell types were solely 
detected on top of the mucosal epithelium. Afterwards, a percentage of cells (16-26%) invaded 
into the mucosa between 24 and 48 hours. Why the transmigration was restricted to a certain 
subpopulation is not clear, but we plan to examine this in the near future. In contrast with moDCs 
and nmCD172a+ cells, blood-derived monocytes did not migrate into deep layers of the lamina 
propria and submucosa, which is consistent with their normal behavior. Blood monocytes mainly 
migrate from vessels toward the mucosal epithelium en route to the lymph and blood circulation, 
not from the apical side of the epithelium toward the basolateral side. A subset of blood monocytes 
leaves the blood circulation, differentiates into macrophages or DCs and patrols healthy tissues, 
including the mucosal epithelium of the respiratory tract (Imhof and Aurrand-Lions, 2004; Auffray 
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et al., 2007; Yang et al., 2014; Randolph et al., 1999). Macrophages destroy pathogens. DCs 
capture antigens and transport them to the draining lymph nodes and blood circulation and present 
antigens to the immune system (Auffray et al., 2007; Jakubzick et al., 2013). In the present study, 
the role of moDCs and nmCD172a+ cells as potential transport vehicles was illustrated by their 
migration into mucosal tissue. We observed that 16-26% of cells crossed the nasal epithelium, and 
1-7% migrated through the lamina propria and submucosa. These results agree with the well-
recognized migratory behavior of mucosal macrophages and DCs, which migrate to draining 
lymph nodes and present antigens to naive T cells (Coombes and Powrie, 2008; Tugizov et al., 
2012; Kissenpfennig et al., 2005). Thus, DCs and nmCD172a+ cells are more agile compared to 
other blood and tissue mononuclear cells.  
Next, we examined the migration pattern of EHV-1-inoculated monocytic cells. The three types 
of monocytic cells were infected to different degrees. The percentage of infected (IEP positive) 
cells was higher in moDCs (13±1.5% at 24 hpi and 10±2.5% at 48 hpi) compared to nmCD172a+ 
cells (11.5±4.5% at 24 hpi and 9±3 at 48 hpi) and blood-derived monocytes (7±2.5% at 24 hpi and 
5±2.5% at 48 hpi). Both EHV-1-inoculated (CFSE+ IEP+/IEP-) and mock-inoculated (CFSE+ IEP-
) monocytic cells migrated into the epithelium and lamina propria to a similar extent. The number 
of EHV-1-infected (CFSE+ IEP+) moDCs and nmCD172a+ cells that passed through the nasal 
epithelium was significantly higher than EHV-1-infected blood-derived monocytes after 48 hours. 
These data are consistent with previous observations on the transmigration of HIV-infected 
macrophages through the paracellular space of intact mucosal epithelia and paracellular space of 
polarized endometrial epithelial cells (Anderson et al., 2010; Carreno et al., 2002). Moreover, HIV-
infected macrophages can transmigrate across intestinal and fetal oral mucosal epithelia (Tugizov 
et al., 2012). These macrophages use adhesion molecules to stay attached to epithelial cells, where 
they perform their antigen uptake and surveillance functions. Once macrophages are activated, 
they utilize cell junctions to migrate back into the tissue. Although infected moDCs and 
nmCD172a+ cells penetrated through the epithelial cells, only moDCs could transfer EHV-1 
through the BM barrier at 24 hours. After 48 hours, nmCD172a+ cells were able to carry EHV-1 
through the BM barrier but to a much lesser extent than moDCs. Considerable evidence indicates 
that DCs are actively involved in the transmigration of pathogens from mucosal surfaces toward 
local lymph nodes. Many pathogens utilize mucosal immune cells and DCs for transport and 
transfer to target cells. Human Immunodeficiency Virus (HIV) is a well-known virus that hijacks 
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immature DCs and transfers them from the apical side of epithelium into the lamina propria 
(Cunningham et al., 2013; Harman et al., 2013). Tugizov et al. reported that 
monocytes/macrophages/Langerhans cells transfer Epstein-Barr virus (EBV), a human 
gammaherpesvirus, into the oral mucosal epithelium and spread the virus within the body (Tugizov 
et al., 2007). Therefore, a similar mechanism might take place in our model system of EHV-1 
transmigration through mucosal epithelium. Blood-derived monocytes appear to take up viruses 
but fail to breach the BM barrier. This finding is likely due to the inability of these cells to 
differentiate into antigen presenting cells (Jakubzick et al., 2013; Palframan et al., 2001). Both 
moDCs and nmCD172a+ cells can capture EHV-1 and provide a path for the virus to penetrate 
intact mucosal epithelia. Thus, moDCs and nmCD172a+ cells may operate as viral transport 
vehicles to local lymph nodes and internal organs via blood circulation.  
In conclusion, our findings illustrate the behavior and function of different monocytic cells within 
the mucosal tissue. These cells become infected with EHV-1 at the respiratory mucosa, the initial 
site of the infection, and transport of the virus from the apical side of the epithelium into the lamina 
propria. Our data demonstrate that monocytic cells clearly play a role in the pathogenesis of EHV-
1 infection. Nevertheless, further studies are needed to confirm this invasion pathway and to 
identify other immune cells and molecules involved in this process. Understanding the 
fundamental aspects of EHV-1 entry during equine upper respiratory tract infection remains a 
critical step for preventing EHV-1 infection and developing further vaccinal strategies and 
virucidal agents. 
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Summary  
The respiratory mucosa is the common port of entry of equine herpesvirus type 1 (EHV-1) and 
several other alphaherpesviruses. An important prerequisite for successful host invasion of the 
virus is to cross the epithelial cell layer and the underlying basement membrane barrier. In the 
present study, an analysis was performed to see if an EHV-1 infection of nasal mucosa epithelial 
cells leads to damage of the underlying basement membrane. A detailed quantitative analysis 
system was set up to determine the impact of the virus replication on different components of the 
basement membrane. Nasal mucosa explants were inoculated with EHV-1 and collected at 0, 24 
and 48 hours post inoculation (hpi). Then, double immunofluorescence stainings were performed 
to detect viral antigen positive cells on the one hand and integrin alpha 6 (ITGA6), laminin, 
collagen IV and collagen VII on the other hand. The thickness of integrin alpha 6, laminin, collagen 
IV and collagen VII was measured in regions of interest (ROI) at a magnification of 200X by 
means of the software imaging system ImageJ. Regions of interest were defined underneath non-
infected and infected regions. In non-infected regions 22 - 28 % of the ROI was stained for integrin 
alpha 6, 18 - 37 % for laminin, 14 - 38 % for collagen IV and 18 - 26 % for collagen VII. In infected 
regions this percentage was significantly decreased for integrin alpha 6 to 0.1 - 9 % and 0.1 - 6 % 
after 24 and 48 hours of inoculation, respectively. Infection did not alter the percentages for 
laminin and collagen IV. For collagen VII an increase in the percentage (from 18 - 26 % to 28 - 
39 %) could be observed underneath EHV-1-infected plaques at 48 hours of inoculation. In 
conclusion, the results revealed a substantial impact of EHV-1 infection on integrin alpha 6 and 
collagen VII, two important components of the basement membrane barrier.  
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1. Introduction 
Equine herpesvirus type 1 (EHV-1) is a ubiquitous alphaherpesvirus and a causative agent of 
different disease symptoms in horses including epidemic respiratory disease, abortion, neonatal 
foal death, equine herpesvirus myeloencephalopathy (EHM), and chorioretinopathy (Allen et al., 
2004; Dunowska, 2014). Despite vaccination, EHV-1 remains a constant threat to horses 
worldwide, mainly because the immune responses induced after both infection and vaccination are 
not fully protective (Bürki et al., 1990). The initial infection starts with replication of EHV-1 in 
the epithelial cells lining the airway mucosa. EHV-1 does not only have a tropism for epithelial 
cells, but also targets monocytic cells and T-lymphocytes, hijacking these cells for transport across 
the basement membrane barrier (Kydd et al., 1994; Vandekerckhove et al., 2010; Gryspeerdt et 
al., 2010; Bannazadeh Baghi and Nauwynck, 2014). At present it is not known by which 
mechanism the basement membrane is crossed by EHV-1-infected immune cells. This is the case 
since there is a discrepancy between the permeability of virus plaques and infected cells across the 
basement membrane.  
The basement membrane is an amorphous, dense, highly cross-linked and sheet-like structure of 
50 - 100 nm in thickness that separates cells from the underlying lamina propria and provides a 
structural support for most epithelia (Kalluri, 2003; Kelley et al., 2014). The basement membrane 
is defined biochemically by its typical components and morphologically by its characteristic 
appearance in electron micrographs which consists of two thin structural layers. The first layer, 
the basal lamina, is synthesized by epithelial cells and the second layer, the reticular lamina, is 
made by fibroblasts. The basal lamina is subdivided into a clear lamina lucida directly under the 
epithelial cells and a structurally opaque lamina densa (Evans et al., 1990; Evans et al., 2010b). 
The main components of the basement membrane are: laminins, type IV collagen, nidogen and the 
heparan sulfate proteoglycans (HSPGs), and also often agrin, fibulins, fibronectin and other types 
of collagen (I, III, V, VI, VII, and XVIII) as well as various integrins, which are plasma membrane 
anchoring proteins that act as a ligand of basement membrane components (Erickson and 
Couchman, 2000; Yurchenco et al., 2004; Yurchenco and Patton, 2009). This extracellular matrix 
forms a barrier underneath the layer of mucosal epithelial cells and contributes to their filter 
function of selecting or permitting the passage of diverse molecules across the corresponding 
barrier (Rippe and Davies, 2011; Ockleford et al., 2013; Mestres et al., 2014). Potential 
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mechanisms for immune cell transmigration through the mucosal basement membrane include: 
transmigration of cells through preformed holes or incisions, proteolytic digestion of extracellular 
matrix components and non-proteolytic force-dependent mechanisms (Rowe and Weiss, 2008; 
Sorokin, 2010). The mechanism by which free viruses or viral infected cells breach the basement 
membrane, in order to invade deeper tissues and thus spread throughout the body, is largely 
unexplored. In the present study the effect of an EHV-1 infection on integrin alpha 6, laminin, 
collagen IV and collagen VII of the nasal mucosal basement membrane barrier was examined. 
2. Materials and Methods 
2.1. Animals and nasal tissue collection 
Nasal mucosa was collected from horses in the slaughterhouse and was used to obtain nasal 
explants. Horses negative for nasal/ocular discharge and lung pathology were selected. All horses 
were between 4 and 8 years old and seropositive for EHV-1. Nasal explants of three individual 
horses were collected. The tissues were transported in phosphate-buffered saline (PBS), 
supplemented with 1 µg/ml gentamicin (Gibco), 1 mg/ml streptomycin (Certa), 1000 U/ml 
penicillin (Continental Pharma), and 5 µg/ml fungizone (Bristol-Myers Squibb) to the laboratory.  
Then, tissues were cut into strips for nasal explant culture. 
2.2. Cultivation of the nasal mucosal explants 
The cultivation of nasal mucosal explants was performed with minor modification as previously 
described (Bannazadeh Baghi and Nauwynck, 2014). In brief, mucosal explants were stripped 
from the surface by the use of surgical blades (Swann-Morton). Then, the stripped mucosa was 
divided into equal explants of 25 mm2 and placed in six-well plates with the epithelial side facing 
up on a fine-meshed gauze and cultured for 24 h (37 °C, 5% CO2) at an air-liquid interface with 
serum-free medium containing 50% DMEM (Invitrogen), 50% Ham’s F-12 GlutaMAX 
(Invitrogen) and supplemented with 0.1 mg/mL gentamicin (Invitrogen), 0.1 mg/mL streptomycin 
(Certa), 100 U/mL penicillin (Continental Pharma) and 0.01 mg/mL fungizone (Bristol-Myers 
Squibb, USA). For virus inoculation, the tissue explants were transferred from the gauzes on 3 ml 
of agarose (50% sterile 3% agarose (low temperature gelling; Sigma) and 50% 2x medium (50% 
2x D-MEM/50% 2x F12)), supplemented with 2 µg/mL gentamicin, 0.2 mg/mL streptomycin and 
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200 U/mL penicillin in a well of a 6-well culture plate with the epithelium facing upwards. 
Additional agarose was added until the lateral surfaces of the mucosa were fully occluded. Only a 
thin film of serum-free medium (50% Roswell Park Memorial Institute medium (RPMI, 
Invitrogen) /50% Dulbecco's Modified Eagle Medium (DMEM, Invitrogen)) supplemented with 
0.3 mg/mL glutamine (BHD Biochemical), 1 µg/mL gentamycin (Invitrogen), 0.1 mg/mL 
streptomycin (Certa) and 100 U/mL penicillin (Continental Pharma)) covered the explants, thereby 
mimicking the air/liquid interface found in the respiratory tract of the living animal. Explants were 
maintained at 37°C in an atmosphere containing 5% CO2. 
2.3. Virus  
EHV-1 strain 03P37, which was isolated from the blood of a paralytic horse in 2003, was used in 
this study (van der Meulen et al., 2003; Garré et al., 2009). The virus stocks used for inoculation 
were at the 6th passage: 2 passages in rabbit kidney cells (RK13) and 4 subsequent passages in 
equine embryonic lung cells (EEL). 
2.4. Virus inoculation and sample collection of nasal explants 
Explants were inoculated with 500 µL of EHV-1 at a titer of 106.5 TCID50/mL for 1 hour at 37 °C 
in the presence of 5% CO2. Afterwards, they were washed three times with medium and further 
incubated for 0, 24 and 48 hours at 37°C with 5% CO2. To avoid drying out during incubation, the 
nasal mucosa was covered with a thin film of serum-free medium. Explants were collected, 
embedded in methylcellose medium (Methocel® MC, Sigma-Aldrich, St. Louis) and frozen at -
70°C. Fifty 12-µm-thick cryosections from each time point were cut and fixed in methanol at -
20°C for 20 minutes. 
2.5. Immunofluorescence staining 
Viral proteins were stained by incubation with biotinylated equine polyclonal anti-EHV-1 IgG 
(van der Meulen et al., 2003), followed by streptavidin-Texas Red® (Molecular Probes, Eugene, 
OR). Subsequently, the basement membrane components of the tissues were stained separately 
with monoclonal mouse anti-integrin alpha 6 antibodies (IgG1, Santa Cruz Bio), polyclonal rabbit 
anti-laminin antibodies (IgG, ab11575; Abcam), goat anti-collagen IV antibodies (IgG, Southern 
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Biotech) and monoclonal mouse anti-collagen VII antibodies (IgG1, Sigma-Aldrich, St.Louis), 
followed by secondary FITC-labeled goat anti-rabbit antibodies, Alexa Fluor® 488 rabbit anti-goat 
IgG, FITC-labeled goat anti-mouse antibodies (Molecular Probes, Eugene, OR). All antibodies 
were diluted in PBS (1:100) and incubated for 1 hour at 37°C and 5% CO2. The nuclei were 
counterstained with Hoechst 33342 (Molecular Probes) for 10 minutes. As a negative control, 12-
µm cryosections of mock-inoculated tissues were stained following the aforementioned protocol. 
Appropriate isotype-matched control antibodies were used to confirm the specificity of each 
antibody. All stainings were analyzed with a confocal laser scanning microscope (Leica TCS SPE 
laser scanning spectral confocal system, Leica Microsystems GmbH, Wetzlar) and the Leica 
confocal software. 
2.6. Basement membrane analysis 
To quantify the basement membrane components under infected (plaques) and non-infected areas, 
a double immunofluorescence staining was performed. By using the software imaging system 
ImageJ, the percentage of pixels positive for integrin alpha 6, laminin, collagen IV and collagen 
VII was measured in standardized regions of interest (50 x 50 pixels) in sections at a magnification 
of 200X (Figure 1). 
2.7. Statistical analysis 
The data were statistically evaluated by analysis of variance (ANOVA) using SAS 9.2 software 
(SAS Institute Inc., Cary, NC, USA). Results are shown represent mean + SD of three independent 
experiments with three different horses (*P < 0.05; **P < 0.01; ns, not significant). 
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Figure 1. Schematic overview of the nasal mucosal basement membrane with its main components. 
The regions of interest (50 × 50 pixels) were set in sections at a magnification of 200X and the 
percentage of pixels positive for different components of the basement membrane were measured 
by using the software imaging system ImageJ.  
 
3. Results 
3.1. Integrin alpha 6 (ITGA6)  
Integrin alpha 6 is present as a full lining underneath the epithelial cells of mock-inoculated nasal 
mucosal tissues: 22 - 28 % in a square of 2500 pixels (region of interest, ROI). Upon inoculation 
with EHV-1, integrin alpha 6 specifically disappeared underneath the EHV-1 positive plaques: 0.1 
- 9 % at 24 hpi and 0.1 - 6 % at 48 hpi (Figure 2).  
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 0 hpi 24 hpi 48 hpi  
Figure 2. Confocal photographs illustrating the lining of integrin alpha 6 (green) and the effect 
of EHV-1 infection in the nasal mucosa epithelial cells (red) at 0, 24 and 48 hours post inoculation 
(hpi). Scale bar: 50 µm. EHV-1 infection in the epithelial cells clearly damaged integrin alpha 6 
(**P < 0.01).  
3.2. Laminin and Collagen IV 
With antibodies against laminin and collagen IV a strong obvious staining was detected underneath 
the epithelial cells of mock-inoculated explants and underneath a plaque of EHV-1 infected cells. 
The thickness of the laminin and collagen IV underneath an EHV-1 plaque at 24 and 48 hpi was 
similar to that of the laminin and collagen IV at 0 hpi and non-inoculated tissues (Figure 3). 
 
    
 0 hpi 24 hpi 48 hpi  
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 0 hpi 24 hpi 48 hpi  
Figure 3. Confocal photographs illustrating the laminin and collagen IV of basement membrane 
(green) and plaques of EHV-1-infected cells (red) at 0, 24 and 48 hpi. Scale bar: 50 µm.  EHV-1 
infection had no impact on laminin and collagen IV. 
3.3. Collagen VII  
Monoclonal antibodies against collagen VII revealed a full lining underneath the epithelial cells. 
Collagen VII thickness was not significantly altered at 24 hpi (Figure 5). However, the thickness 
of collagen VII was significantly (P < 0.05) increased below plaques of EHV-1 infected cells (28 
- 39 % in a square of 2500 pixels) after 48 hpi compared to mock-inoculated tissues (18 - 26 %). 
Collagen VII thickness was not significantly altered at 24 hpi (Figure 5). 
   
 0 hpi 24 hpi 48 hpi  
Figure 5. Confocal photographs illustrating the collagen VII of the basement membrane (green) 
and plaques of EHV-1-infected cells (red) at 0, 24 and 48 hpi Scale bar: 50 µm. An EHV-1 infection 
caused thickening of the area containing collagen VII after 48 hpi (*P < 0.05).  
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4. Discussion 
The airway epithelium constitutes the first barrier of defense against environmental microorganism 
by providing not only a mechanical and chemical barrier to impede entry of foreign particles, but 
also by its ability to orchestrate both the innate and adaptive immune responses. The basement 
membrane forms a layer underneath the respiratory epithelial cells which plays an important role 
in the maintenance of mucosal tissue architecture and orchestrates the homing of immune cells as 
well as tissue regeneration during pathological events (Timpl, 1989; Yurchenco, 2011). Mucosal 
basement membrane components are attractive targets for adherence and invasion by various 
microorganisms. Equine herpesvirus type 1 (EHV-1) is an invasive virus of the respiratory mucosa. 
After initial replication in the epithelial cells, EHV-1 can cross the basement membrane barrier via 
single infected mononuclear immune cells, which then progress to the blood vessels of the lamina 
propria and the draining lymph nodes (Kydd et al., 1994; Gryspeerdt et al., 2010; Vandekerckhove 
et al., 2010; Dunowska, 2014). So far, the effect of an EHV-1 infection of epithelial cells on the 
underlying basement membrane is unknown. 
In the present study a nasal mucosal explant model was used to evaluate the effect of EHV-1 
infection of epithelial cells on the integrity of the basement membrane. It has already been shown 
that EHV-1 spreads horizontally in a plaquewise manner in the respiratory epithelium (Gryspeerdt 
et al., 2010; Vandekerckhove et al., 2010). In contrast to SHV-1, BoHV-1 and HSV-1, EHV-1-
induced plaques cannot breach the basement membrane barrier (Glorieux et al., 2007; Glorieux et 
al., 2011; Steukers et al., 2012, Vandekerckhove et al., 2010). However it penetrates in a more 
discrete manner, by exploiting individual monocytic cells and T-lymphocytes, and using them as 
a Trojan horse (Vandekerckhove et al., 2010; Bannazadeh Baghi and Nauwynck, 2014). While no 
generally accepted model of immune cell transmigration through the mucosal basement membrane 
exists, some potential mechanisms have been proposed: transmigration of cells through preformed 
holes or incisions, proteolytic digestion of extracellular matrix components and non-proteolytic 
force-dependent mechanisms (Rowe and Weiss, 2008; Sorokin, 2010). To determine if some 
components of the basement membrane are affected during EHV-1 infection the concentration and 
localization of integrin alpha 6, laminin, collagen IV and collagen VII under the plaques were 
investigated via quantitative image analysis.  
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Integrins are cell-surface molecules that play a role in cell-to-cell, cell-to-matrix adhesion and cell 
migration mechanisms (Mercurio, 1995; Wang et al., 2005). They have been identified on many 
different cell types, markedly in cells of an epithelial nature which interact strongly with 
fibronectin and laminin in the basement membrane (Kajiji et al., 1989; Müller et al., 2008). 
Considerable evidence exists that some integrins such as integrin alpha 6 beta 4 play a functional 
role in the hemidesmosomal anchoring complex (Liebert et al., 1994; Borradori and Sonnenberg, 
1999). It is also well-known that during inflammation, activated integrins firmly bind VCAM-1 
and ICAM-1 to stabilize adhesion and support leukocyte migration (McGettrick et al., 2012). 
However, little is known about the relative expression, distribution or function of different 
integrins on epithelial cells as well as in leukocyte subpopulations and endothelial cells. In the 
present study it was shown that integrin alpha 6 (ITGA6) completely disappeared underneath the 
EHV-1-infected zone. It is tempting to speculate that EHV-1-triggered degradation of integrin 
alpha 6 on the mucosal surfaces may facilitate transmigration of infected monocytic cells and T-
lymphocytes through the mucosal basement membrane barrier en route to the blood vessels of the 
lamina propria and the draining lymph nodes. Alteration of integrin alpha 6 during viral infection 
suggests that this integrin has more than one function: an anchoring function in normal resting 
mucosal epithelial cells, and a second function in effecting the motility of leukocyte cells during 
infection. It is known that some microorganisms degrade basement membrane components with 
their secretory or surface-bound proteases, or using ‘hijacked’ host proteases (such as 
plasminogen), during inflammatory responses resulting in increased tissue damage. During 
infection, partially degraded and exposed basement membrane components are attractive targets 
for adherence of pathogens, which can be achieved by various microbial surface-exposed adhesive 
proteins (Vanlaere and Libert, 2009). 
The basic framework of the basement membrane is thought to be created by two independent and 
distinct networks of laminin and type IV collagen (Yurchenco and Patton, 2009; Mestres et al., 
2014). Infection of mucosal epithelial cells with EHV-1 did not change the structure of laminin 
and collagen IV under the plaques. Since laminin and collagen type IV serve as the main branched 
structural components of the mucosal barrier, this suggests that the main barrier function of the 
basement membrane may remain intact during EHV-1 infection. One of the interesting results in 
this study was the increased thickness of the collagen VII under the EHV-1 plaques. Type VII 
collagen is a major component of the anchoring fibrils network of the mucosal basement 
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membrane that attaches the epithelium to the extracellular matrix (Osawa et al., 2000; Evans et al., 
2010a). Previous studies addressing interactions between collagen VII and unpolymerized 
basement membrane molecules demonstrated that the amino-terminal, non-collagen-like domain 
1 (NC1) of collagen VII interacts with laminin 5 and collagen IV (Chen et al., 1997; Rousselle et 
al., 1997). Other studies reported direct but weak interactions between collagen VII and collagen 
I (Brittingham et al., 2006; Villone et al., 2008). Liebert and colleagues also showed co-localisation 
of collagen VII with integrin alpha 6 beta 4 (Liebert et al., 1994). It is possible that in equine nasal 
mucosa, there is a direct interaction between collagen VII and integrin alpha 6. Since we showed 
that EHV-1 infection leads to integrin alpha 6 degradation, this may lead to impaired collagen-
integrin interactions. Degradation of integrin alpha 6 during EHV-1 infection may then disturb the 
anchoring of collagen VII which, although speculative at this point, in turn may then lead to the 
observed swelling of collagen VII. It will be interesting to further investigate whether the swelling 
of collagen VII in the absence of integrin alpha 6 during EHV-1 infection of mucosal epithelium, 
may activate migration of mononuclear cells in the underlying tissues, since such migrating 
mononuclear cells may be hijacked by EHV-1 during passage of infected region.  
In conclusion, the study delivers new insights on the presence and localization of different 
components of mucosal basement membrane molecules in normal and EHV-1-infected tissues. 
We found that EHV-1 infection has a major effect on two important basement membrane 
components, namely integrin alpha 6 and collagen VII. The interesting aspect of this finding was 
that they were inversely affected: while integrin alpha 6 was degraded by infection, the collagen 
VII layer increased in thickness during infection. It will therefore be interesting to examine 
whether modulation of these particular proteins plays an important role in the migration of the 
virus through the basement membrane.  
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Outline 
Mucosal surfaces of the respiratory tract are the primary site of replication of countless viruses and 
bacteria. These areas are under rigorous control of professional antigen presenting cells (APCs), 
such as dendritic cells (DCs) and monocytes/macrophages. In addition to these, mucosal 
lymphocytes, and even epithelial cells play important roles in modulating immune responses to 
incoming pathogens.  
During a respiratory tract infection, the number of APCs, notably DCs, increase in the mucosal 
tissues by chemotactic influx of precursors that originate primarily from circulating monocytes 
(Auffray et al., 2007; Geissmann, 2007). Migration of these monocytic cells to non-lymphoid 
peripheral tissues such as the nasal mucosa and lungs, is mediated by so called ‘‘inflammatory’’ 
chemokines. Exposure of these cells to antigens in peripheral tissues initiates cell maturation 
(Steinman, 1991). During maturation, the monocytic cells increase the surface expression of co-
stimulatory molecules such as CD38, CD40, CD80 CD83, and CD86 (Reis and Sousa, 2006). They 
also change their expression of cell surface chemokine receptors (Alvarez et al., 2008). One of the 
important roles of monocytic cells at the mucosal sites is to initiate and regulate innate immune 
responses, acquire foreign antigens, and present antigens in mucosa-associated lymphoid tissues 
(MALT) such as NALT (nasopharynx- or nose-associated lymphoid tissue), LALT (larynx-
associated lymphoid tissue) and BALT (bronchus-associated lymphoid tissue) (Długońska and 
Grzybowski, 2012; Soloff and Barratt-Boyes, 2010). 
Some pathogens, particularly viruses, are specialized in infecting migrating mucosal monocytic 
cells during their passage within and outside the mucosa. The respiratory tract is the main port of 
entry for equine herpesvirus type 1 (EHV-1). After primary replication in the epithelial cells of the 
upper respiratory mucosa, EHV-1 crosses the basement membrane barrier by hijacking mucosal 
leukocytes, mainly monocytic cells and T lymphocytes, and spreads in the underlying lamina 
propria, reaching blood vessels and lymphatic vessels (Gryspeerdt et al., 2010; Vandekerckhove 
et al., 2010). Via the blood circulation, EHV-1-infected leukocytes disseminate to important 
internal organs such as the pregnant uterus, central nervous system (CNS) and lymphoid organs 
(Gryspeerdt et al., 2010; Patel and Heldens, 2005). How EHV-1-infected leukocytes invade the 
mucosa and ultimately reach the target organs is still not elucidated. Unraveling the mechanism of 
transmigration of EHV-1-infected mononuclear cells throughout the epithelium and basement 
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membrane barrier of the mucosa and submucosa may open new strategies to interfere with the 
invasion of this alphaherpesvirus and manage the disease.      
Inspired by this knowledge, mucosal monocytic cells in the nasal mucosa were characterized 
(Chapter 3.1) and their migration pattern was compared with those of blood-derived monocytic 
cells and monocyte-derived DCs in nasal mucosal explants. Afterwards, the impact of EHV-1 
infection on the migration of these monocytic cells through equine nasal mucosa was investigated 
(Chapter 3.2). The data presented here also revealed the impact of EHV-1 on integrin alpha 6 and 
different components of the basement membrane in the nasal mucosa: laminin, collagen IV and 
collagen VII (Chapter 4). 
 
Monocytic lineage cells 
The isolation of equine nasal mucosal mononuclear phagocytes and their characterization had not 
been reported yet. In the present PhD thesis, a new technique was described to isolate equine nasal 
mucosal monocytic cells (CD172a+ cells). Morphological examination showed that large cells 
extended their dendrites onto the plastic wells after 24 hours of culture. The cells were spherical 
in the beginning and became triangular with typically vacuoles and prominent pseudopodia after 
three days. From three till four days they were crawling more actively using dendrites and 
pseudopodia. After five and six days, the majority of the isolated cells firmly attached to the culture 
dish. The functional and phenotypical characterization of these monocytic lineage cells revealed 
that the isolated population consists of mononuclear phagocytic cells, notably immature DC.   
The morphology of tissue resident macrophages is heterogeneous in terms of their function and 
phenotype (Gordon and Taylor, 2005; Wynn et al., 2013). They express a vast majority of sensing 
molecules, including scavenger receptors, nuclear hormone receptors, pattern recognition 
receptors, and cytokine receptors, which allow macrophages to monitor tissue microenvironments 
and act as pivotal cells for controlling infection and tissue damage (Geissmann et al., 2010a; Okabe 
and Medzhitov, 2014). Monocyte-derived DCs have already been generated in various species, 
including: pigs, cattle, sheep, dogs, cats, and horses (Howard et al., 1999; Paillot et al., 2001; Chan 
et al., 2002; Bienzle et al., 2003; Mauel et al., 2006; Wang et al., 2007). Cultivation and 
characterization of equine monocyte-derived DCs, in terms of morphology and function, have been 
largely studied (Siedek et al., 1997; Mauel et al., 2006; Dietze et al., 2008; Cavatorta et al., 2009). 
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However, the isolation and characterization of mucosal mononuclear phagocytes, such as mucosal 
DCs and macrophages were not yet performed in most animals, including horses. 
 
The resemblance of equine nasal mucosal CD172a+ cells (nmCD172a+ cells) to immature 
dendritic cells 
The upper respiratory tract of horses is an important site for invading pathogens (e.g. viruses such 
as EHV-1 and EAV). As a consequence it plays a crucial role in host defense via the mucosal 
immune response. To this end, local monocytic cells such as macrophages and various DC subsets 
are believed to play a key role in the ablility to respond vigorously to microbial pathogens 
(Banchereau and Steinman, 1998).  
In the present PhD research, preparation of single cell suspension from equine nasal tissues was 
done by collagenase type IV and DNase I. Subsequently antibodies against CD172a were used for 
isolation of mucosal monocytic lineage using MACS. We evaluated the morphology, phenotype 
and function of equine nasal mucosal CD172a+ cells and compared them with blood-derived 
monocytes and blood monocyte-derived DCs. From the morphological point of view, cytoplasmic 
extrusions and diverse branched protoplasmic extensions were observed in the isolated nasal 
mucosal CD172a+ cells. The triangular isolated monocytic cells, showed a typical dendritic 
morphology. The key morphological characteristic of DCs is the presence of countless membrane 
processes that extend out from the main cell body (similar to dendrites on neurons) (Steinman and 
Cohn, 1973; Merad et al., 2008). CD1c, CD83, CD172a, CD206 and MHC II were used to 
characterize equine nasal mucosal CD172a+ cells. The expression of CD1c+ cells was significantly 
higher in isolated CD172a+ cells from the nasal mucosa compared to blood-derived monocyte and 
monocyte-derived DCs. This is in line with the result of isolated mucosal DCs from the epithelium 
and lamina propria of the human respiratory tract (Jahnsen et al., 2004). The expression of CD83, 
which is one of the widely known maturation markers on human and murine DCs on nasal mucosal 
CD172a+ cells, was slightly higher than on blood-derived monocytes and monocyte-derived DCs. 
Due to the slightly higher expression of CD83 in the nasal mucosal CD172a+ cells it is tempting 
to speculate that they are semi-mature cells in the mucosal area. These results correlate with the 
expression of the mannose receptor CD206 in both immature blood monocyte derived DCs and 
isolated nasal mucosal CD172a+ cells. The low expression of MHC class II on the isolated cells, 
is another indication that these cells are rather immature cells. It is also well-documented that 
General discussion 
 
113 
 
immature DCs are able to take up antigens, via receptor-mediated endocytosis and 
macropinocytosis, more than their mature counterparts. The DC maturation causes down-
regulation of the antigen-uptake machinery, up-regulation of costimulatory and adhesion 
molecules, maturation marker CD83, and peptide-MHC complexes (Banchereau and Steinman, 
1998; Berchtold et al., 1999). In our study, the freshly isolated nasal mucosal CD172a+ cells 
showed a high phagocytic activity. These findings are in line with the reported strong endocytic 
activity of monocytic cells in the human upper respiratory mucosa (Von Garnier et al., 2005).  
Hence, the isolated nasal mucosal CD172a+ cells resemble immature DCs based on morphology, 
function, and stage of differentiation. A better understanding of nasal mucosal mononuclear 
immune cells could shed new light on how viruses (such as arteriviruses and alphaherpesviruses) 
may hijack these crucially important cells during invasion and immune evasion in the mucosal 
area and how they may modulate the immune response against secondary infections with other 
viral and bacterial pathogens. 
 
Modulation of monocytic cell migration by viral infection 
Monocytic cells represent important cellular targets for many viruses. They can enter in lymphoid 
tissues during inflammation and give rise to macrophages and inflammatory DCs (Gordon and 
Taylor, 2005; Luster et al., 2005; Geissmann et al., 2010a). These mononuclear phagocytes are 
considered to be an important cellular target for some viruses such as human immunodeficiency 
virus type-1 (HIV-1) and EHV-1 (Haase, 2010; Gryspeerdt et al., 2010; Vandekerckhove et al., 
2010).  
One of the goals of this doctoral research (Chapter 3, part B) was to identify and to decipher new 
immune evasion mechanisms of EHV-1, focusing on the different types of monocytic cell 
transmigration in the nasal mucosal tissue. We designed a system to evaluate the migration of 
different types of monocytic cells in the upper respiratory tract and to determine their importance 
for EHV-1 transmigration. The explant model allowed us to study the movement of non-infected 
monocytic cells and the transmigration of EHV-1-infected cells within nasal mucosa. This in vitro 
model of nasal mucosal epithelium is a valuable system to provide novel information on the early 
pathogenesis of not only EHV-1 but also other animal and human viruses. Indeed, behavior of the 
transmigration of these mononuclear cells alone and virus-infected cells in the in vitro explant 
model is highly reminiscent of the in vivo situation in the natural hosts. 
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A percentage of non-infected monocytic cells (16-26%) invaded the mucosa between 24 and 48 
hours after the cells were added on top of the epithelium. We could thereby show that blood-
derived monocytes did not migrate into deep layers of the lamina propria and submucosa in our in 
vitro system. However, we demonstrated that monocyte-derived DCs and nasal mucosal CD172a+ 
cells act as potential transportation vehicles, by migration into deep mucosal tissue (1-7%). These 
observations agree with the well accepted migratory behavior of mucosal macrophages and DCs, 
which breach the basement membrane barriers, in order to be able to migrate to draining lymph 
nodes and present antigens to naïve T cells (Kissenpfennig et al., 2005; Coombes and Powrie, 
2008; Tugizov et al., 2012).  Monocytic cells migrate from blood vessels towards regions of 
inflammation. However it is not mentioned that they also migrate back. Therefore nasal 
macrophages and DCs are all ideal vehicles for pathogens to enter its host at the respiratory 
mucosa.  
With the help of the established explant model, we evaluated the migration pattern of three EHV-
1-inoculated monocytic cell types. Our results indicated that both EHV-1-inoculated and mock-
inoculated monocytic cells migrated into the epithelium and lamina propria to a similar 
extent.Similarly to mock-inoculated cells, the number of EHV-1-infected monocyte-derived DCs 
and nasal mucosal mCD172a+ cells that passed throughout the nasal epithelium was significantly 
higher than EHV-1-infected blood-derived monocytes after 48 hours. Despite the fact that all types 
of monocytic cells were able to capture EHV-1 from the mucosal surface (which results in the 
infection of the cells) and to penetrate into mucosal epithelia, only monocyte-derived DCs could 
transfer EHV-1 through the basement membrane barrier at 24 hours. After 48 hours, nasal mucosal 
CD172a+ cells were able to carry EHV-1 through the basement membrane barrier but to a much 
lesser extent than monocyte-derived DCs. Blood-derived monocytes took up EHV-1, but failed to 
breach the basement membrane barrier. This may be due to the inability of these cells to 
differentiate into antigen presenting cells (Palframan et al., 2001; Jakubzick et al., 2013). 
Considerable evidence indicates that mononuclear cells, notably DCs and macrophages, are 
actively involved in the transmigration of pathogens from mucosal surfaces towards local lymph 
nodes. Our results are consistent with the previous observations on the transmigration of HIV-
infected mononuclear cells through the paracellular space of intact mucosal epithelia and 
paracellular space of polarized endometrial epithelial cells (Carreno et al., 2002; Anderson et al., 
2010; Tugizov et al., 2012). 
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In conclusion, we found that while EHV-1 can infect three types of monocytic cells to a varying 
extent, the virus did not obviously change the migratory behavior of the cells in a positive or 
negative way. Moreover, we could show that monocyte derived dendritic cells and nasal mucosal 
CD172a+ cells are able to carry EHV-1 from the surface of nasal mucosa to the deep lamina propria 
and submucosa, en route to the lymph and blood circulation. These data suggest that these 
monocytic cell types may play a pivotal role in the early stages of EHV-1 infection. 
 
Role of basement membrane barrier in EHV-1 invasion 
In Chapter 4 the invasive effect of EHV-1 infection (neurovirulent strain, 03P37) on different 
components of the basement membrane was evaluated. Components of the basement membranes, 
integrin alpha 6, laminin, collagen IV and collagen VII, function as mechanical containment 
molecules that protect tissues against infection of pathogens. The presence of these different 
components in normal and EHV-1-infected nasal mucoal tissues was investigated by measuring 
their thickness with the software imaging system ImageJ. 
Little is known about the transmigration and penetration of alphaherpesviruses from the apical side 
of mucosal epithelium towards the basolateral side. Previous work, in our laboratory, revealed that 
PRV breaches the basement membrane plaquewise after epithelial infection, involving protease-
mediated (trypsin-like serine protease) disintegration of the extracellular matrix, in order to invade 
lamina propria and distribute in the body (Glorieux et al., 2011). In contrast, EHV-1 does not cross 
the basement membrane in a plaquewise manner but instead infects resident monocytic cells within 
the respiratory epithelium and appears to abuse their motile nature to invade the host 
(Vandekerckhove et al., 2010). The involvement of different components of the extracellular 
matrix and notably the basement membrane barrier in the invasion process of alphaherpesviruses 
remains poorly understood.  
Populations of leukocytes constantly travel through basement membrane barriers to patrol host 
tissues in their search for microbial pathogens (Ley et al., 2007). During pathologic events such as 
neoplastic events and microbial infection, cells can misuse normal basement membrane 
transmigration programs. To this end, the basement membrane pore size needs to be transformed. 
This happens mainly through protease-dependent disintegration and is largely reliant on matrix 
metalloproteinases (MMP) (Sherwood, 2006; Kelley et al., 2014). Indeed, leukocytes can traffic 
across the basement membrane barrier, without leaving detectable perforations. However, the 
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exact mechanism of both physiologic and pathologic cell transmigration remains complex and, to 
a great extent, unresolved. Therefore, further studies into the transmigration of immune cells from 
the basement membrane barrier are needed. In this thesis, four proteins of extracellular matrix 
(integrin alpha 6, laminin, collagen IV and collagen VII), which are mainly associated with the 
basement membrane barrier, were assessed. It goes without saying that all mucosal-invasive 
viruses as well as free EHV-1 and EHV-1-infected cells have to overcome and breach this 
obstructive membrane. This will help further invasion of viruses into underlying lamina propria 
and ultimately into their end target organs. Here we could demonstrate that an EHV-1 infection 
clearly affects some components of the nasal mucosal barrier and the virus degrades integrin alpha 
6. 
Integrins are cell-surface molecules that play a role in cell-to-cell adhesion, cell migration 
mechanisms and act as ligands of basement membrane components (Mercurio, 1995; Wang et al., 
2005). Relative expression, distribution or function of different integrins on epithelial cells as well 
as in leukocyte subpopulations and endothelial cells remains a highly undiscovered field. Since 
integrin alpha 6 is disintegrated so strongly during an EHV-1 infection, it is interesting to look 
further into its mechanism and to examine if it is helping monocytic cells to find their way to the 
infected epithelial cells. Elucidating this mechanism could bring new insights on how to block it. 
Research should focus on which viral components are modulating this process. In this context, 
mutants can shed new light on the mechanism. Deleting the viral genes that are encoding proteins 
that are responsible for the integrin alpha 6 disintegration may help to attenuate EHV-1 and to 
develop vaccines.  Because EHV-4, which is closely related to EHV-1, is much less pathogenic 
because it does not invade via leukocytes, it would be worth looking at its interaction with integrin 
alpha 6. Some microorganisms degrade extracellular matrix components with their secretory or 
surface-bound proteases, or ‘hijack’ host proteases. As mentioned above, the present study shows 
a disintegration of integrin alpha 6 underneath EHV-1 infected regions. With this knowledge, it 
may be questioned whether this phenomenon is responsible for the transmigration of infected 
monocytic cells and T-lymphocytes throughout the mucosal basement membrane barrier en route 
to the blood vessels of the lamina propria and the draining lymph nodes. Another finding in this 
study was that while integrin alpha 6 was disintegrated, collagen VII under the EHV-1 plaques 
increased in thickness. It is possible that there is a direct interaction between collagen VII and 
integrin alpha 6 in the equine nasal mucosa. Damage of integrin alpha 6-collagen VII interaction 
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may allow the collagen VII layer to swell. Another possibility is that the production of collagen 
VII is activated due to EHV1 infection, leading to a thicker layer. It should be noted that EHV-1-
infected cells and free viruses did not affect the thickness of laminin and collagen IV in the mucosal 
area.  
Based on the results from the present PhD thesis, the following hypothetical pathogenesis model 
may be forwarded as illustrated in Figure 1. During an EHV-1 infection of epithelial cells, integrin 
alpha 6 becomes disintegrated. The disconnection of the bonds between epithelial cells and 
collagen VII leads to the loosening of the infected epithelial cells and swelling of collagen VII. 
These structural changes are attracting monocytic cells that are guided in the direction of infected 
epithelial cells. Afterwards, the monocytic cells become infected and move in a physiological way 
back to lymph and blood vessels. 
 
Figure 1. Hypothetical explanation for the invasion mechanism of EHV-1-infected mononuclear 
cells through the basement membrane.  
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Summary 
 
Equine herpesvirus type 1 (EHV-1) is an alphaherpesvirus causing respiratory problems, abortion, 
neonatal foal death, chorioretinopathy and equine herpesvirus myeloencephalopathy (EHM). The 
upper respiratory tract (especially nasal mucosa) is the primary site of virus replication. After local 
replication, EHV-1 spreads via a cell-associated viremia reaching the internal target organs such 
as uterus and central nervous system. Replication in endothelial cells of these organs can result in 
abortion or nervous system disorders. Peripheral blood mononuclear cells (PBMC), notably 
monocytic cells and T-lymphocytes, play a key role in the pathogenesis of an EHV-1 infection, 
both in naïve and in immune horses. These immune cells perform a crucial role in transporting 
EHV-1 from the primary site of replication to the target organs. However, the lack of knowledge 
about the invasion strategies of immune EHV-1-infected cells is an important obstacle. 
 
Chapter 1, is divided into two sections. First, an introduction is given about EHV-1 in general, 
describing its phylogenetic background, taxonomy and virus structure, genomic organization and 
replication cycle, pathogenesis, latency and symptoms. Second, an overview of cell migration is 
given, with a focus on immune cell transmigration including leukocytes trafficking, recirculation 
of leukocyte, leukocyte rolling and activation during tethering, integrins in leukocyte migration, 
leukocyte recruitment in inflammation and the role of ICAM-1 and VCAM-1 in leukocyte 
adhesion. 
 
In Chapter 2, the general goals of the study described in the present dissertation were put forward. 
The aims include the isolation and characterization of nasal mucosal monocytic cells from the 
upper respiratory mucosa. Then, the migration pattern of the isolated monocytic cells and two 
blood-derived cells (blood-derived monocytes and blood monocyte-derived DCs) in nasal mucosal 
explants were examined together with the effect of EHV-1 infection on the migratory behavior of 
these cells. Finally, the effect of EHV-1 infection on different components of the basement 
membrane were evaluated. 
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In Chapter 3 A, a detailed characterization of monocytic cells (CD172a+ cells), residing in the 
equine nasal mucosa was performed from five horses. Nasal mucosal CD172a+ cells were isolated 
from collagenase type IV and DNase I digested equine nasal mucosa fragments by magnetic 
activated cell sorting. Equine blood-derived monocytes and blood monocyte derived dendritic cells 
(moDCs) were isolated and generated to compare them with the isolated mucosal cells. Surface 
markers of all three cell types were determined by flow cytometry. The expression of cell surface 
markers in the nasal mucosal cells was as follows: 90% CD172a+, 30% CD1c+, 46% CD83+, 42% 
CD206+ and 28% MHC II+. In blood-derived monocytes: 96% CD172a+, 4% CD1c+, 11% CD83+, 
9% CD206+, 72% MHC II+ and on blood monocyte derived DCs: 99% CD172a+, 13% CD1c+, 
30% CD83+, 51% CD206+ and 93% MHC II+. Functional analysis of the cells was done by 
measuring the uptake of FITC conjugated ovalbumin (FITC-OVA). The CD172a+ nasal mucosal 
cells were functionally able to endocytose FITC-OVA but to a lesser degree than monocyte-
derived DCs. These results demonstrated that the isolated CD172a+ nasal mucosal cells resemble 
immature DCs in the nasal area. 
  
In Chapter 3 B, we aimed to evaluate how EHV-1 effects the migratory behaviors of monocytic 
cells in the mucosal explant model. EHV-1 replicates extensively in the epithelium of the upper 
respiratory tract, after which it can easily spread throughout the body via a cell-associated viremia 
in mononuclear leukocytes (mostly monocytic cells and T lymphocytes) reaching the pregnant 
uterus and central nervous system. In Chapter 3 A, three monocytic cell types were isolated and 
characterized. These monocytic cells were labeled with a fluorescent dye (CFSE) and were 
transferred to the apical part of a polarized mucosal explant system. We monitored the migration 
pattern of monocytic cells and the effect of EHV-1 on transmigration of these cells by means of 
confocal microscopy at different time points. We could show that one-fourth of both EHV-1-
inoculated and mock-inoculated monocyte-derived DCs and nasal mucosal CD172a+ cells moved 
into the nasal epithelium. A fraction moved even further into the lamina propria and submucosa. 
Virus-inoculated blood-derived monocytes did not move through the basement membrane barrier. 
In general we could conclude that nasal mucosal CD172a+ cells and monocyte derived DCs are 
able to transport EHV-1 into the submucosa which facilitates a generalized infection with the virus.  
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In Chapter 4, the aim was to determine the impact of an infection with EHV-1 on different 
components of the basement membrane. Since an important prerequisite for successful host 
invasion of the virus is to cross the epithelial cell layer and the underlying basement membrane 
barrier, the focus of the analysis was the possible damaging of the underlying basement membrane 
by the EHV-1 infection. In this context, a detailed quantitative analysis was set up which allowed 
an in-depth analysis of thickness of areas stained for integrin alpha 6, laminin, collagen IV and 
collagen VII under the virus positive plaques in comparison with the thickness of the membrane 
in the non-infected areas. The results indicated that (i) integrin alpha 6 disappeared under the EHV-
1 plaques, (ii) the thickness of collagen VII increased and (iii) the thickness of laminin and collagen 
IV stayed unaffected compared to mock-inoculated tissues. The results thus revealed that integrin 
alpha 6 and collagen VII are highly involved in the EHV-1 invasion process.  
 
In Chapter 5, the main findings of this dissertation are discussed. Monocytic cells do play an 
important role in the transmigration process of EHV-1 through the mucosal area, the basement 
membrane and the further spread of the virus throughout the body. Their patrolling functions allow 
the virus to hijack them and use them as a transportation means into the tissue. We discussed the 
isolation and characterization of nasal mucosal CD172a+ cells and used blood monocytes and 
blood-derived moDCs as controls. It was found that while nasal monocytic cells originally are 
meant to fulfill a preventive function against infection in the nasal mucosal epithelium, they 
become the very means by which the virus is spread throughout the body. Here it was clearly 
shown that the consequences of EHV-1 infection of nasal mucosa are the degradation of integrin 
alpha 6 and the thickening of collagen VII. This interplay of these basement membrane 
components facilitates the transmigration of infected monocytic cells into the tissue.
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Samenvatting 
 
Equiene herpesvirus type 1 (EHV-1) is een alfa-herpesvirus dat ademshalingsproblemen, spontane 
abortus, neonatale veulen sterfte, chorioretinopathie en equiene herpesvirus myeloencephalopathie 
(EHM) veroorzaakt. De primaire locatie van virus replicatie is het neusslijmvlies van de bovenste 
ademhalingswegen. Na de lokale replicatie, verspreidt EHV-1 zich via een cel-geassocieerde 
viremia en bereikt hiermee de interne doelorganen, zoals de baarmoeder en het centrale 
zenuwstelsel. Virale replicatie in de endotheliale cellen van deze organen kan in een spontane 
abortus of zenuwstelsel aandoeningen resulteren. Perifere bloed mononucleaire cellen (PBMC), 
met name monocyten en T-lymfocyten, spelen een belangrijke rol bij de pathogenese van een 
EHV-1 infectie, zowel in naïeve als in immune paarden. Deze immuuncellen vervullen een 
cruciale rol bij het transport van EHV-1 uit de primaire plaats van replicatie naar de doelorganen. 
Echter, het gebrek aan kennis over de invasie strategieën van EHV-1-geïnfecteerde immuuncellen 
is een belangrijk obstakel. 
 
Hoofdstuk 1 is verdeeld in twee secties. Eerst wordt er een inleiding gegeven over EHV-1 in het 
algemeen, met een beschrijving van de fylogenetische achtergrond, taxonomie en virusstructuur, 
genomische organisatie en replicatiecyclus, pathogenese en symptomen. Ten tweede wordt er een 
overzicht gegeven van de cel migratie, met een nadruk op immuuncel transmigratie waaronder 
verplaatsing, recirculatie, rollen en activering tijdens migratie van leukocyten, 
leukocytaantrekking bij ontstekingen en de rol van ICAM-1 en VCAM-1 in leukocytenadhesie. 
 
In Hoofdstuk 2 worden de algemene doelstellingen van het in dit proefschrift beschreven 
onderzoek naar voren gebracht. De doelstellingen omvatten de isolatie en karakterisering van 
nasale mucosale monocytische cellen van het bovenste luchtwegen slijmvlies. Ook het 
migratiepatroon van de geïsoleerde monocytische cellen en twee bloed afgeleide cellen (bloed 
monocyten en bloed-monocyt-afgeleide DCs) in nasale mucosale explantaten samen met het effect 
van EHV-1 infectie op het migratiegedrag van deze cellen vormt een belangrijke doelstelling. Een 
laatste doelstelling tenslotte omvat het nagaan van het effect van EHV-1 infectie op verschillende 
componenten van het basale membraan. 
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In Hoofdstuk 3 A, werd er een gedetailleerde karakterisatie van monocytische cellen (CD172a+ 
cellen), welke aanwezig zijn in het equiene neusslijmvlies, uitgevoerd bij vijf paarden. Nasale 
mucosale CD172a+ cellen werden geïsoleerd, uit de door collagenase type IV en DNase I 
afgebroken equiene neusslijmvlies fragmenten, door middel van magnetisch geactiveerde 
celsortering. Equiene bloed monocyten en van bloed monocyten afgeleide dendritische cellen 
(moDCs) werden geïsoleerd en gegenereerd om te kunnen vergelijken met de geïsoleerde 
mucosale cellen. Oppervlaktemarkers van alle drie de celtypes werden bepaald door 
flowcytometrie. De expressie van celoppervlakmarkers in de nasale mucosale cellen was als volgt: 
90% CD172a+ 30%, CD1c+, 46% CD83+, CD206+ 42% en 28% MHC II+. In bloed monocyten: 
96% CD172a+, 4% CD1c+, 11% CD83+, 9% CD206+, 72% MHC II+ en op van bloed monocyten 
afgeleide DC's: 99% CD172a+, 13% CD1c+, 30% CD83+, 51% CD206+ en 93 % MHC II+. 
Functionele analyse van de cellen werd uitgevoerd door meting van de opname van FITC 
geconjugeerd ovalbumine (OVA-FITC). De CD172a+ nasale mucosale cellen konden actief FITC-
OVA endocytoseren maar in mindere mate dan monocyt afgeleide DCs. Deze resultaten toonden 
daarmee aan dat de geïsoleerde CD172a+ nasale mucosale cellen op onrijpe DCs lijken. 
 
In Hoofdstuk 3 B, hebben we geëvalueerd hoe EHV-1 het migratie gedrag van monocytcellen in 
de mucosale explantaatmodel beïnvloedt. EHV-1 repliceert excessief in het epitheelweefsel van 
de bovenste luchtwegen, waarna het zich gemakkelijk kan verspreiden in het lichaam via een 
celgebonden viremie in mononucleaire leukocyten (meestal monocytische cellen en T-
lymfocyten) met als laatste bestemming de drachtige baarmoeder en het centrale zenuwstelsel. In 
hoofdstuk 3 A werden drie monocytaire celtypen geïsoleerd en gekarakteriseerd. Deze 
monocytische cellen werden gemerkt met een fluorescente kleurstof (CFSE) en overgebracht naar 
het apicale deel van een gepolariseerde mucosale explantaat systeem. We volgden het 
migratiepatroon van monocytische cellen en het effect van EHV-1 op transmigratie van deze cellen 
door middel van confocale microscopie op verschillende tijdstippen. Wij konden aantonen dat één 
vierde van zowel de EHV-1 geïnoculeerde als de mock-geïnoculeerde monocyt afgeleide DCs en 
nasale mucosale CD172a+ cellen zich verplaatst hadden naar het nasale epitheel. Een fractie had 
zich nog verder verplaatst naar de lamina propria en submucosa. Virus geïnoculeerde bloed 
monocyten waren niet door het basaal membraan barrière gemigreerd. In het algemeen kunnen we 
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dus concluderen dat nasale mucosale CD172a+ cellen en van bloed monocyten afgeleide DCs 
EHV-1 kunnen transporteren naar de submucosa, wat een algemene infectie met het virus 
vergemakkelijkt.  
 
In Hoofdstuk 4, was het het doel om de gevolgen van een infectie met EHV-1 op de verschillende 
onderdelen van het basaalmembraan te bepalen, aangezien een belangrijke voorwaarde voor een 
succesvolle gastheerinvasie van het virus erin bestaat dat het virus de epitheliale cellaag en 
onderliggende basaalmembraan passeert. De focus van de analyse lag op de mogelijke 
beschadiging van het onderliggende basaalmembraan door de EHV-1 infectie. In dit verband werd 
een gedetailleerde kwantitatieve analyse op punt gesteld, die een grondige analyse van de dikte 
van gebieden gekleurd voor integrine alfa 6, laminine, collageen IV en collageen VII onder virus 
positieve plaques toestond ten opzichte van de dikte van het membraan in de niet-besmette 
gebieden. De resultaten gaven aan dat (i) integrine alfa 6 degradatie onderging onder de EHV-1 
plaques, (ii) de dikte van de collageen VII laag toegenomen was en (iii) de dikte van de laminine 
en collageen IV lagen onveranderd bleven in vergelijking met de mock-geïnoculeerde weefsels. 
De resultaten onthulden hiermee dat integrine alfa 6 en collageen VII mogelijks betrokken zijn bij 
het EHV-1 invasie proces. 
 
In Hoofdstuk 5 worden de belangrijkste bevindingen van dit proefschrift besproken en 
bediscussieerd. Monocytische cellen spelen een belangrijke rol in het proces van EHV-1 
transmigratie door het mucosale gebied, het basale membraan en de verdere verspreiding van het 
virus in het lichaam. Hun patrouillerende functies laten het virus toe om ze te kapen en ze als een 
transportmiddel te gebruiken naar de weefsels. Daarnaast wordt de resultaten besproken die 
aantoonden dat EHV-1 infectie van het neusslijmvlies, zowel de afbraak van integrine alfa 6 een 
verdikking van de collageen VII laag als gevolg heeft. De wisselwerking van deze 
membraancomponenten vergemakkelijkt mogelijks de transmigratie van geïnfecteerde 
monocytische cellen in het weefsel. 
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